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ABSTRACT 
 
Ticks bites are a source of morbidity and mortality for humans and animals. 
Chemicals have been insufficient for tick control whereas an anti-tick vaccine may be an 
effective alternative. Hosts use serpins to control their immune pathways therefore ticks 
may inject serpins into the host for the same purpose. Amblyomma americanum 
transcriptome data were analyzed to determine extent and diversity of serpins. Candidate 
serpins were assayed for function against 17 proteses and for ablity to affect blood 
coagulation and platelet aggregation.  Spliced serpin constructs consisting of putatively 
immunogenic regions of selected serpins were designed for expression and vaccine 
trials.  
A. americanum expresses 122 unique serpins. The greatest diversity of serpins 
were in males and in feeding ticks. Forty percent were conserved in other ticks. A. 
americanum serpins 4 and 8 were selected for characterization as representatives of 
similar serpin clusters. These serpins bound host antibodies to tick saliva indicating they 
are immunogenic and used in feeding. Serpin 8 inhibited inflammatory proteases 
cathepsin G and proteinase 3. Serpin 4 inhibited inflammatory proteases cathepsin G and 
chymase, and the cysteine protease papain. Neither serpin affected blood coagulation 
however, serpin 4 delayed platelet aggregation. A spliced serpin construct was cloned in 
bacteria and yeast cells, however recombinant proteins failed to express. Results indicate 
serpins 4 and 8 function in the vertebrate host as counter-defense serpins and thus may 
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be useful as anti-tick vaccine candidates, however their relative importance in tick 
feeding physiology will need to be addressed using an alterantive protocol. 
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CHAPTER I  
 
INTRODUCTION 
 
Tick Biology and Medical and Veterinary Importance 
Ticks (Order: Acari, Superfamily: Ixodoidea) are parasitic arthropods that are 
obligatory hematophagous. While there are three families of ticks; Ixodidae, Argasidae, 
and Nutallielidae, the Ixodidae, or hard ticks, so called because of the hard appearance of 
their exoskeleton, collectively cause the largest health and economic burden worldwide. 
There are four stages to their life cycle: the inactive egg stage, and the active and blood-
feeding larval, nymphal, and adult stages. Ticks parasitize a wide variety of vertebrates 
including reptiles, birds, and mammals. At least 39 species of ixodid ticks are commonly 
found on animals and at least 60 species of ixodid ticks have been cited as found feeding 
on humans, with 23 commonly found on humans (Dantas-Torres et. al., 2012; Estrada-
Peña and Jongejan, 1999). Ticks of the family Ixodidae may be classified as one-, two-, 
or three- host ticks. One-host ticks spend their entire life cycle on the same host; two-
host ticks spend both immature stages of their life cycle on the host, finding a new host 
only at the adult stage; and three-host ticks change hosts with each molt. Unlike many 
other hematophagous parasites, ticks are unique in the duration of time they spend on 
their host, which can last for days at the immature larval and nymphal stages, and for 
weeks at the adult stage. Ticks are telmophagous, feeding from a pool of blood created 
in the skin following laceration of the blood vessel. Consequent to their hematophagous 
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lifestyle and their prolonged feeding times, tick parasitism manifests itself into a variety 
of negative consequences for their hosts. Tick feeding has been documented to cause 
severe direct effects including paralysis and toxicosis from injected tick toxins, allergic 
reactions, anemia and exsanguination in heavy infestations, reduced livestock 
productivity, damage to skin impacting the economic value of hides, and death (Jongejan 
and Uilenberg, 2004; Estrada-Peña and Jongejan, 1999; Klompen et. al., 1996). Wildlife 
also suffer from the direct effects of tick parasitism. For example, in the northern United 
States, moose populations with heavy winter tick (Dermacentor albipictus) infestations 
average 33,000 ticks per moose (with up to 100,000 per moose also documented) 
(Severud and DelGiudice, 2015). Heavy infestations in these moose leads to a loss of fur 
and often death (Samuel, 2004). However, of primary concern perhaps is the 
transmission of disease-causing pathogens by ticks. Ticks may transmit a wide diversity 
of pathogenic organisms to their hosts including viruses, bacteria, protozoa, and 
helminthes (Sonenshine and Roe, 2014). 
In livestock production, ticks are considered the most important arthropod vector 
of disease agents (Sonenshine, 1991; de la Fuente et. al., 2008). In livestock production, 
an estimated 80% of the world’s cattle are affected by disease-causing tick-borne 
pathogens. The most serious diseases in livestock caused by tick-borne pathogens are 
babesiosis, anaplasmosis, theileriosis, and heartwater (Jongejan and Uilenberg, 2004; 
Marcelino et. al., 2012). In domestic pets, notable disease caused by tick bites are Lyme, 
cytauxzoonosis, canine ehrlichiosis, hepatozoonosis, rickettsiosis, and anaplasmosis 
(Smith et al., 2012; Rizzi et al., 2015; Baneth et al., 2015; Dantas-Torres et al., 2012). 
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Humans, while frequently parasitized by ticks, are considered only an incidental host, 
and for many years ticks and diseases stemming from their parasitism were primarily a 
veterinary problem. However, following the description of Borrelia burgdorferi as a 
causative agent for Lyme disease in the 1980’s there was a paradigm shift regarding the 
impact of ticks in public health (Burgdorfer et. al., 1982; Johnson et. al., 1984). Between 
1982 and 2001, the list of human diseases caused by tick-vectored pathogens ballooned 
with the addition of 15 new bacterial pathogens (Parola and Raoult, 2001). While in 
2011, the global count of diseases in humans caused by tick-vectored pathogens was 17 
(Day, 2011), this number has been on the rise. It was previously reported that there are 
10 human diseases caused by tick-vectored pathogens in North America (Dantas-Torres 
et al., 2012). Today however, that list has increased to 15 (Tick-borne diseases of the 
United States, 2016; Savage et. al., 2013; Dantas-Torres et al.; 2012), and ticks rank just 
behind mosquitoes in their medical burden to humans (Sonenshine, 1991; de la Fuente 
et. al., 2008a). In the U.S., the most common diseases in humans caused by tick-vectored 
pathogens are Lyme disease, Rocky Mountain spotted fever (RMSF), human monocytic 
ehrlichiosis, human granulocytic anaplasmosis, tularemia, and babesiosis (Martin and 
Romero, 2012), although diseases caused by Powassan and Heartland viruses are also of 
great concern due to the morbidity and potential lethality of the ensuing diseases 
(Piantadosi et al., 2015).   
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Amblyomma americanum Biology and Medical and Veterinary Importance 
Amblyomma americanum, long considered a nuisance tick species, has become 
one of the most important vectors in the United States, and is the most important tick 
pest in the southern United States, both in veterinary medicine and in public health 
(Brannan et al., 2014; Childs and Paddock 2003). A. americanum is a three-host tick and 
an aggressive biter with a reputation of indiscriminately parasitizing a wide variety of 
vertebrate hosts in all active stages of its life. Humans are no exception, where it is not 
uncommon for A. americanum to parasitize humns in geographic regions suffering from 
heavy population numbers of this species (Mixson et. al., 2006; James et. al., 2001). 
While currently found only in North America, recent years have seen the geographic 
range of A. americanum expand from strictly southeastern regions of the United States to 
the northeast and Midwestern regions (Keirans and Lacombe, 1998; Mixson et. al., 
2004). Recent surveys for A. americanum distributions have classified this species as 
established in 32 states throughout the Southeast, South Central, and Midwest regions, 
and all along the eastern seaboard as far north as Maine (Springer et al., 2014). 
In humans, A. americanum is responsible for the transmission of Ehrlichia 
chaffeensis, Ehrlichia ewingii, Francisella tularensis, Rickettsia amblyommii, and the 
causative agent of southern tick-associated rash illness (STARI) (Schulze et. al., 2011; 
Telford III and Goethert, 2004; Telford III et al., 2008; James et al., 2001; Goddard 
2009; Tick-borne Diseases of the United States, 2016). While any disease caused by 
bacteria of the genus Ehrlichia may be called ehrlichiosis, infection with E. chaffeensis 
is also called human monocytic ehrlichiosis. Like many diseases caused by tick-borne 
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pathogens, ehrlichiosis symptoms are flu-like in nature including fever, fatigue, and 
muscle aches (Ehrlichiosis, 2013). Ehrlichiosis can be fatal, and since 2008 there have 
been thousands of reported cases of this disease (Nichols Heitman et al., 2016). 
Francisella tularensis is a serious bacterial pathogen, and the associated disease, 
tularemia, causes varying symptomology that may include ulceration at the bite site and 
lymph node swelling (Tularemia, 2015; Signs & Symptoms, 2015). In 2014, there were 
180 cases of tularemia reported to the CDC and over 200 cases reported in 2013. Most 
cases of tularemia occur in Arkansas, Oklahoma, Kansas, and Missouri (Statistics, 
2015). R. amblyommii is a spotted fever group (SFG) rickettsial species with 
undetermined pathogenicity in humans (Sayler et al., 2014). However, its implication in 
human disease comes from the fact that it has been detected in RMSF-like rashes after 
bites from A. americanum (which does not transmit the causative agent of RMSF), while 
RMSF has been reported in areas where A. americanum is the predominant tick species 
(not the Dermacentor species that are responsible for RMSF) (Sayler et al., 2014). 
Another incomplete epidemiological mystery is the southern tick-associated rash illness 
(STARI), where the disease is obvious but the pathogen has yet to be isolated. STARI is 
diagnosed as a Lyme-like bullseye rash appearing at the bite site of A. americanum ticks 
(rather than Ixodes scapularis ticks) (Masters et al., 2008; Southern tick-associated rash 
illness, 2015).    
 Additionally, A. americanum has been shown to carry Heartland virus; this new 
virus having been first detected in 2009 and subsequently found in 13 states (Heartland 
Virus, 2014; McMullan et. al., 2012; Savage et al., 2013). In the six years since its 
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discovery, Heartland virus infection has been confirmed in ten cases and two of those 
infected have died (Heartland Virus, 2014; McMullan et. al., 2012; Savage et al., 2013; 
Muehlenbachs et al., 2014; Wormser and Pritt, 2015; Williams, 2014). Accumulating 
evidence suggests that this virus is more common than currently appreciated, and that 
more cases have likely occurred but have been overlooked or alternatively diagnosed 
(Doucleff, 2015). In humans, diseases caused by tick-vectored pathogens may be 
significantly under-diagnosed due to the non-specific symptoms (flu-like symptoms) that 
accompany many of the diseases, together with the fact that tick attachment sometimes 
goes undetected even in humans.  
Because animals are unable to groom themselves to the extent that humans 
usually do, the health burdens from tick parasitism on animals extend beyond tick 
pathogen transmission. In cattle, parasitism by A. americanum alone results in lower 
weight gain, damage to hides, problems with fertility, secondary infections at the bite 
site, and even death; resulting in estimated total economic losses of more than $165 
million USD to the industry (Brannan et al., 2014; Polito et al., 2013). Domestic pets not 
only suffer the direct effects of A. americanum parasitism, but may also be subject to 
pathogenic organisms vectored by this tick. In domestic cats, A. americanum 
transmission of the protozoan Cytauxzoon felis results in a variety of clinical signs 
including dehydration, anorexia, lethargy, depression, and most cats die from infection 
(Reichard et. al., 2010; Rizzi et al., 2015). A. americanum also affects wildlife; its 
predilection towards white-tailed deer as a host results in the transmission of Theileria 
cervi, which can be fatal due to anemia and leukocytosis (Wood et al., 2013; de la 
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Fuente et. al., 2008; Waldrup et. al., 1992). There are few vaccines available that protect 
against the pathogens transmitted by ticks, therefore, prevention of disease by these 
pathogens is primarily achieved through tick control. 
Current Tick Control Methods: Insufficiencies and the Vaccine Alternative 
Ticks are currently controlled primarily through the use of acaricidal chemicals 
(Bissinger and Roe, 2010; George et. al., 2004; Redondo et. al., 1999, Pound et. al., 
2000). The most common chemicals used against ticks include organophosphates 
including coumaphos, ethion, diazinon, and chlorfenvinphos; amidines including 
amitraz; pyrethroids including cypermethrin, deltamethrin, and cyhalothrin;  macrocyclic 
lactones including ivermectin; and spinosad (Ghosh et al., 2007; Lopez-Arias et al., 
2014; Shyma et al., 2012; Guerrero et al., 2012).  Even though acaricides have proven 
effective in the short term, they do not offer permanent solutions due to a variety of 
serious limitations. Several acaricides and repellents have shown effective against A. 
americanum specifically, including deltamethrin (Schulze et al., 2001) spinosad, 
amitraz, permethrin, and chlorpyrifos (Miller et al., 2011), and the repellent DEET 
(Carroll et al., 2008). 
One of these limitations is acaricide resistance which has been documented in 
ticks repeatedly in a pattern described as ‘paralleling’ the development of acaricides 
(Alonzo-Diaz et al., 2013; Shyma et al., 2012; Miller et al., 2001). Ticks may develop 
acaricide resistance through three mechanisms: target site insensitivity, enhanced, 
insensitivity enhanced metabolism, or reduced penetration (Guerrero et al., 2012).  In the 
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target site insensitivity mechanism, a genetic mutation in susceptible ticks leads to a 
change in the target site which no longer binds the pesticide resulting in resistance 
towards the drug (Guerrero et al., 2012; Rosario-Cruz et al., 2009). For example, in R. 
microplus amino acid changes in the target site for pyrethroids, the voltage-gated sodium 
channel, has led to resistance in some populations of this tick species against this class of 
acaricides (He et al., 1999). More recently and also in R. microplus, evidence suggests a 
similar gene mutation in the RmβAOR gene, which codes for the octopamine receptor, is 
responsible for resistance to amitraz (Baron et al., 2015; Corley et al., 2013). Metabolic 
acaricide resistance may involve changes in the tick’s ability to metabolize the acaricide 
or in the ability of the tick to sequester the drug (Guerrero et al., 2012).  Studies indicate 
this type of resistance may be involved in R. microplus resistance to coumaphos through 
enhanced cytochrome P450 monooxygenase (cytP450) activity (Guerrero et al., 2007; Li 
et al., 2003). Resistance by a reduced penetration of acaricides into ticks has only been 
documented in laboratory ticks (Nolan and Schnitzerling, 1986; Schnitzerling et al., 
1983). Extensive development of acaricide resistance and the tendency for ticks to 
develop simultaneous resistance to multiple classes of acaricides undermines their use in 
tick control. Unfortunately, the cost of developing new acaricides is steep, estimated at 
over $100 million (Graf et al., 2004; Willadsen, 2008; de la Fuente et al., 2007). 
Furthermore, acaricide use has generated concerns surround contamination of the 
environment and animal food products (George et al., 2004; Shapiro et. al., 1986).  
As a result, it has become clear that acaricide use as a long-term control method 
will be insufficient and must be supplemented or replaced with a method(s) that 
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overcomes these limitations. There are currently few alternatives to acaricidal chemicals. 
While there are many documented natural predators of ticks including birds, spiders, 
beetles, and ants (Samish and Rehacek, 1999), their contribution has not been enough to 
keep tick populations below the acceptable threshold for prevention of direct and 
indirect effects of ticks in veterinary and public health. Some evidence suggests ticks 
may be controlled through the use of tick pathogens such as entomophagous fungi or 
nematodes (Samish et al., 2004; Kirkland et al., 2004; Kaaya and Hassan, 2000) or the 
manipulation of endosymbionts for tick control (Ghosh et al., 2007), however these ideas 
have yet to materialize into successful control alternatives. In the case of entomophagous 
fungi and nematodes, the primary limiting factor is the lack of an appropriate 
formulation (Samish et al., 2004). However, their proposed application in tick habitat 
may not be feasible for the control of certain tick species, such as three-host ticks, which 
spend the majority of their life off-host and would be difficult to target in the 
environment.  
A validated alternative or complementary tick control strategy is the 
immunization of hosts against tick feeding (Rodríguez et. al. 1995; Willadsen et. al., 
1995; Kumar et. al., 2009; Canales et. al., 2009; Merino et. al., 2011; Mulenga et. al., 
1999; Galaï et. al., 2012; Saimo et. al., 2011; Sugino et. al., 2003; Prevot et. al., 2007). 
The idea of immunizing animals (cattle) against tick-vectored pathogens, or even tick 
infestation, by deliberately exposing those animals to tick feeding is more than 100 years 
old (Johnson and Bancroft, 1919; Willoughby, 1904; Dalrymple et al., 1899). However, 
it was not until tick antigens could be selectively singled-out for purification that an anti-
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tick vaccine could reach levels of protection well beyond pre-exposure to tick feeding or 
immunization with tick homogenates (Mulenga et al., 1999; Kemp et al., 1986; Johnston 
et al., 1986). Through successive fractionation and purification a key antigen of R. 
microplus midguts was identified; Bm86 (de la Fuente et al., 2007). As a midgut protein, 
Bm86 was described as a ‘concealed’ antigen because the protein is not presented to the 
host during feeding as in the case of salivary proteins (Sonenshine and Roe, 2014). The 
use of concealed antigens was based on the idea of targeting essential proteins in ticks 
(Nuttal et al., 2006). Vaccine trials in cattle using this 650 amino acid antigen resulted in 
less female ticks feeding to repletion, a reduced engorgement weight, and a lower 
fecundity for ticks (de la Fuente et al., 2007). 
The Bm86 antigen was protective enough to result in the first two 
commercialized anti-tick vaccines: GAVAC (Bm86) and TickGARD (Bm86 and Bm95) 
(Rodríguez et. al. 1995; Willadsen et. al., 1995). These vaccines have been used to 
successfully control ticks in Australia, Mexico, Cuba, Brazil, and Colombia (de la 
Fuente et al., 2007). TickGard is not commercialized but Gavac is still in use today 
(Schetters et al., 2016; Suarez et al., 2016). The application of these vaccines generated 
exciting results, including a reduction in the need for acaricidal use and disease 
incidence in cattle. The economic impact of this vaccine was an estimated savings in the 
millions of dollars for the cattle industry (de la Fuente et. al., 2007; Redondo et. al., 
1999). 
Despite the many successes, these vaccines are limited by several factors. 
Among the issues surrounding the vaccines are their limited use to primarily ticks in the 
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genus Boophilus (now Rhipicephalus) (de la Fuente et. al., 1999), thus lacking broad 
utility across tick species.  Another cited reason for their limited success is a lack of a 
knockdown effect as seen with acaricide use (de la Fuente et. al., 2007), which gives the 
impression that vaccination does not work as well as chemical alternatives. The 
difficulties experienced with GAVAC/TickGARD, however, have only encouraged 
efforts to find a better replacement(s). In the years since its discovery and 
commercialization, research endeavors have continued in pursuit of additional anti-tick 
vaccine target antigens. As a result, a variety of promising antigens have been 
discovered and their experimental use in vaccine trials have further demonstrated the 
ability of anti-tick vaccines to reduce tick infestation, tick survival, engorgement 
weights, ova deposition, and target transcript abundance, among other parameters 
(Kumar et. al., 2009; Canales et. al., 2009; Merino et. al., 2011; Mulenga et. al., 1999; 
Galaï et. al., 2012; Saimo et. al., 2011; Sugino et. al., 2003).  
Many of these studies have continued with the idea of using concealed antigens. 
In mice immunized with H. longicornis P27/30 recombinant protein, larvae had a much 
lower attachment rate (31.1%) than controls (98%) and larvae, nymphs, and adults took 
longer to feed than controls (You, 2004). Using recombinant embryo protein from R. 
microplus, Boophilus Yolk pro-Cathepsin (BYC), a vaccine efficacy of 25.24% was 
reported in bovine trials (Leal et al., 2006). More recently, the recombinant protein of a 
Bm86 homologue found in Hyalomma anatolicum (Haa86) was used in calf 
immunization trials that resulted in 36.5% of females failing to attach and feed as 
compared to 10.1-12.4% for controls (Azhahianambi et al., 2009). A vitellogenin-
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degrading cysteine endopeptidase (VTDCE) was extracted and purified from R. 
microplus eggs and in bovine trials this vaccine efficiency using this protein was 
reported at 21% (Seixas et al., 2008). Although expressed in salivary glands, Hq05 from 
Haemaphysalis qinghaiensis was determined to be a concealed antigen and in vaccine 
trials ticks feeding on immunized sheep engorged to a lower average weight, laid 40% 
less eggs, and laid eggs that hatched 37% less than controls (Gao et al., 2009). In another 
trial, Amblyomma hebraeum 75% of females failed to engorge on rabbits immunized 
with recombinant male testicular protein voraxin (Weiss and Kaufman, 2004), while for 
R. appendiculatus recombinant protein of the voraxin homolog, voraxin-α, was used to 
immunize rabbits resulting in lower engorgement weights, laid fewer eggs, while 38.6% 
did not lay eggs at all (Yamada et al., 2009). In R. microplus recombinant subolesin was 
used to immunize cattle with a vaccine efficacy of 37-44% (Shakya et al., 2014).  
Manny of the newly sought after anti-tick vaccine antigens, however, are not 
concealed antigens. With the idea that salivary gland proteins can be used as vaccine 
antigens and subsequently serve as a natural booster to vaccination each time a host is 
subsequently exposed to a tick (Willadsen, 2004) these proteins are being heavily 
explored. For example, a salivary gland protein antigen from Haemaphysalis 
longicornis, p29, was tested as a vaccine in rabbits and resulted in reduced female 
engorgement weights as well as 40-56% mortality in immatures (Mulenga et al., 1999).  
Rabbits immunized with H. longicornis HL34 recombinant saliva proteins resulted in 
increased tick mortality during and after feeding (Tsuda et al., 2001). In vaccine trials 
using guinea pigs, immunization with the R. appendiculatus putative cement protein 64P 
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resulted in infestation rates reduced by 48% for nymphs and 70% for adults (Trimnell et 
al., 2002). Zhou et al., (2006) found a low attachment rate and high mortality rate for R. 
haemaphysaloides nymphs and a high mortality rate for adults feeding rabbits 
immunized with the recombinant saliva protein RH50. In an example of cross-resistance 
potential of anti-tick vaccine candidates, recombinant H. longicornis glutathione S-
transferase salivary gland protein was used to immunize cattle, while cattle were then 
challenged with R. microplus larvae infestation with a reported 57% efficacy of the 
vaccine (Parizi et al., 2011). In another vaccine trial using a cocktail of antigens, cattle 
were immunized with three previously validated anti-tick vaccine antigens (VTDCE, 
BYC, and GST-HI) and challenge-infested with R. microplus. Immunized cattle gained 
more weight and suffered less engorging females than non-immunized controls, and the 
effect of the vaccine cocktail was greater than vaccination with individual components 
alone (Parizi et al., 2012).  
Several other studies, though reporting an overall vaccine efficacy, failed to find 
a statistical difference between parameters of control and treatment groups (Parizi et al., 
2011; Seixas et al., 2008; Leal et al., 2006). While many studies report a high impact of 
vaccination (Trimnell et al., 2002; Weiss and Kaufman, 2004; You, 2004), results of 
other studies were more moderate in their impact on tick feeding. Since vaccines 
employing a single antigen usually do not have sufficient efficacy, one possibility for 
improvement is to use a cocktail of antigens (Willadsen, 2008), as at least one study has 
begun to do (Parizi et al., 2012). However, as yet there are no further candidates for anti-
tick vaccine commercialization. Thus, the hunt for the right anti-tick vaccine 
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candidate(s) continues and one family of proteins has been particularly advocated for: 
the serine protease inhibitor (serpin) family (Mulenga et al., 2001). 
  
Serine Protease Inhibitors (Serpins)  
In general, the balance between proteases and protease inhibitors is essential to 
regulation of normal homeostasis across life: from microbes, to plants, to animals. In 
vertebrates, many critical physiological pathways such as blood coagulation, immune 
complement activation, and inflammation are mediated by proteases, particularly those 
of the serine catalytic type (Qureshi et al., 2012, Demetz and Ott, 2012, Loebbermann et 
al., 2012, Zhou et al., 2012, Héja et al., 2012, Forneris et al., 2012, Ichinose, 2012). In 
turn, most of these serine proteases are controlled by serine protease inhibitors (serpins). 
Where protease inhibitors fail to control proteases, disease may ensue (Kanoh et al., 
2012). Among the diseases stemming from dysfunctional serpin activity are cirrhosis, 
emphysema, blood coagulation disorders, and dementia (Stein and Carrell, 1995; Davis 
et al., 1999; Gooptu and Lomas, 2009; Mocchegiani et al., 2011; Benson and Wilkes, 
2012; Bosche et al., 2012; Gatto et al., 2013). Because serpins are used in vertebrate 
systems to shut off immune pathways, it was hypothesized that ticks use their own 
serpins to shut down the immune systems of their vertebrate hosts during feeding 
(Mulenga et al., 2001). Serpins were suggested as anti-tick vaccine candidates as a result 
of their role in vertebrate physiology 
Serpins differ from other protease inhibitors because of their larger size of ~350-
400 amino acid residues and mechanism of inhibition. Serpins are classified as trapping 
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inhibitors, forming an irreversible complex with their target protease (Rawlings et al., 
2004, and Gubb et al. 2010). In serpin-protease interactions, the target protease initiates 
the interaction with the inhibitor. The target protease binds a bait pseudo-substrate 
peptide region in the serpin referred to as the reactive center loop (RCL) (Khan et al., 
2011, Bird and Whisstock 2011, Huntington, 2011). The cleavage of the serpin RCL 
(Bird and Whisstock 2011) triggers a conformational change that leads to the protease 
being irreversibly trapped. Serpins are also characterized by a secondary structure fold 
consisting of 7-9 α-helices and 3 β-sheets, the consensus N-terminus motif NAVYKFG 
(Gettins, 2002), and an exposed consensus 21 amino acid RCL (Gettins, 2002). Within 
the RCL region (E17-[E/K/R]16-G15-[T/S]14-X13-[AGS]12-9-X8-1-X1’-4’) the first 
eight amino acid residues are conserved across taxa, while the remaining 13 residues 
tend to be unique to each serpin (Gettins, 2002). Numbering of the 21 amino acid 
residues in the RCL is based on the numbering system by Schechter and Berger (1967), 
where residues on the amino-terminal side of the scissile bond, (P1-P1) are not primed 
while those on the carboxy-terminal side are primed. Protease cleavage of serpins occurs 
at the P1-P1 scissile bond.  
Serpins in Ticks and as Anti-tick Vaccine Candidates 
Although serpins in other organisms have been reported in the literature for 
decades (Tewksbury, 1983; Carrell and Owen, 1985; Pannekoek et al., 1986), their 
presence in ticks was first reported in the literature in 2001 (Mulenga et al.). Prior to 
advances in DNA technology, proteases inhibitors had to be detected by purifying them 
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from crude tick protein extracts (Limo et al., 1991, Vermeulen et al., 1988, Willadsen 
and McKenna, 1983). With the recent wave of genomics and transcriptomics, however, 
multiple putative serpins have now identified from multiple tick species including I. 
scapularis, I. ricinus, A. maculatum, A. maculatum, R. microplus, R. appendiculatus, H. 
longicornis, and H. haemaphysaloides,  (Leboulle et al., 2002a; Nene et al., 2002; 
Sugino et al., 2003; Mulenga et al., 2003a,b, 2008; Imamura et al., 2005, 2006; Ribeiro 
et al., 2006; Prevot et al., 2007; Chalaire et al., 2011; Yu et al., 2013). With the recent 
sequencing of the I. scapularis genome as well as many tick transcriptomes (Gulia-Nuss 
et al., 2016; Pagel Van Zee et al., 2007; Francischetti et al., 2005; Anderson and 
Valenzuela, 2008; Aljamali et al., 2009; Donohue et al., 2010; Ribeiro et al., 2011; 
Bissinger et al., 2011; Richards et al., 2015; Tan et al., 2015) the full picture of serpins in 
ticks is beginning to emerge. At least 45 serpins are predicted to be expressed in I. 
scapularis on the basis of unique putative RCLs (Mulenga et al., 2009). Karim et al. 
(2011) report at least 32 different serpin transcripts expressed in A. maculatum. Tirloni et 
al., (2014) described 18 serpins in R. microplus and a further four were described shortly 
after (Rodriguez-Valle et al., 2015).  
In A. americanum, an analysis of cDNAs determined that this tick species 
expresses at least 17 different serpin transcripts (Mulenga et al., 2007). In this 
dissertation, that number has expanded to 122 unique A. americanum serpins (Porter et 
al., 2015). Tick encoded serpins conform to the consensus structure of serpins (Mulenga 
et al., 2003b, 2008, 2009). Knowledge about tick serpins is accumulating, however, the 
full picture of their roles in tick physiology remains speculative. In ticks (and in other 
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parasitic species), protease inhibitor function is viewed from two perspectives: one being 
their significance in regulating the homeostasis of the parasitic organism itself, and the 
other being significance in regulating interactions between the parasite and its host.  
Accordingly, serpin function must not only be validated but also characterized as 
targeting either endogenous or exogenous (host) proteases. 
Research Significance 
Emerging functional data suggesting a role of tick serpins in facilitating tick 
counter-defense against the vertebrate immune system and a potential for their use as 
anti-tick vaccine antigens warrants further investigation into the scope and function of 
tick serpins. The objectives of this dissertation serve to fill several knowledge gaps in 
tick serpin research. This dissertation serves to determine the diversity and count of 
serpins in A. americanum. By determining the extent and diversity of serpins in A. 
americanum, this dissertation will generate a comprehensive list of serpins expressed in 
this species with which vaccine candidates may be selected. Due to the limited time and 
funding for research in combination with a steadily-increasing veterinary and public 
health burden of ticks and the pathogens they transmit, it is imperative to set a 
prioritization plan for investigating the potential of serpins as anti-tick vaccine antigens. 
Within the scope of ixodid serpins, this dissertation serves to set a prioritization 
plan for selecting candidates for empirical validation of vaccine efficacy. Although 
originally identified strictly as inhibitors of serine proteases (Hunt and Dayhoff, 1980) 
subsequent studies have shown that certain serpins are non-inhibitory, although they 
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perform equally important functions such as hormone delivery, cancer pathogenesis, 
angiogenesis, and neuronal function (Lee et al., 2012, Tanaka et al., 2011, Hoshina et al., 
2010, Carrell and Zhou, 2011).  Therefore, it is necessary to validate the putative 
inhibitory function of in silico-annotated serpins. In comparing expression data, in silico 
functional predictions, and intra- and inter-specific sequence comparisons that have been 
empirically validated, this dissertation contributes to developing a prioritization plan. 
Ultimately the real test of vaccine utility lies in immunization trials. By combining 
bioinformatics, biological and biochemical characterization, and vaccine trials this 
dissertation completes the scope of empirical analysis required to qualify or disqualify 
serpin candidates from anti-tick vaccine inclusion. 
In addition to the potential of serpins as useful anti-tick vaccine antigens, this 
family of proteins may be applicable in a medical context. The potential medical utility 
of serpins stems from the variety of human diseases caused by deficiencies in blood 
coagulation and platelet aggregation pathways including hemophilia A and B, and von 
Willebrand’s disease (Dahlbäck, 2005). An even larger list of diseases associated with 
aberrant immune function has been documented including allergic rhinitis, asthma, 
myasthenia gravis, Graves’ disease, multiple sclerosis, inflammatory bowel disease, and 
type I diabetes (Abbas et al., 2011). Because ticks secret pharmacologically active 
components into their host that have evolved to function efficiently in vertebrate 
systems, they are potentially attractive candidates for medical application. Indeed, the so 
called medicinal leech, Hirudo medicinalis yielded a potent thrombin inhibitor that was 
developed into a drug to treat coagulation disorders (de Kort et al., 2005; Markwardt, 
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2002). Biochemical characterization is the first step in determining the activity and 
potency of serpins against immune system-modulatory proteases. Therefore, this 
dissertation also serves to further validate the potential use of A. americanum serpins in a 
medical context. 
20 
CHAPTER II 
BIOINFORMATIC ANALYSES OF MALE AND FEMALE AMBLYOMMA 
AMERICANUM TICK EXPRESSED SERINE PROTEASE INHIBITORS (SERPINS)* 
Introduction 
Ticks are among the most successful ectoparasites of humans and animals. In 
livestock production, an estimated 80% of the world’s cattle are affected by tick-borne 
diseases (TBD), of which the most important include theileriosis, babesiosis, 
anaplasmosis, and Heartwater (Marcelino et al., 2012). In addition to pathogen 
transmission, tick feeding has been documented to cause severe direct effects including 
paralysis, exsanguination, reduced livestock productivity, and damage to skin impacting 
the economic value of hides (Klompen et al., 1996; Jongejan and Uilenberg, 2004). In 
public health, ticks have been implicated in the transmission of 17 diseases affecting 
humans, and the list continues to grow (Day, 2011; Dantas-Torres et al., 2012; Savage et 
al., 2013). 
A. americanum has emerged among the most important tick species in public 
health in the United States. A. americanum  transmits multiple TBD agents, including 
Ehrlichia chaffeensis, E. ewingii, Rickettsia amblyommii, Francisella tularensis, the as 
* Reprinted with permission from “Bioinformatic analyses if male and female Amblyomma
americanum tick expressed serine protease inhibitors (serpins)” by Lindsay Porter, Zeljko Radulovic,  
Tae Kim, Gloria R. C. Braz, Itabajara Da Silva Vaz Jr., and Albert Mulenga, 2015. Ticks and Tick-borne 
Diseases, 6, 1, 16-30, Copyright [2015] by Elsevier.  
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yet undescribed causative agent of southern tick associated rash illness (STARI), 
Cytauxzoon felis, Theileria cervi, and the emerging human Heartland virus (Waldrup et 
al., 1992; James et al., 2001; Childs and Paddock, 2003; Telford and Goethert, 2004; 
Telford et al., 2008; de la Fuente et al., 2008; Goddard, 2009; Schulze et al., 2011; 
Savage et al., 2013). For many years, this tick was mainly distributed in the southeastern 
United States, but has now been reported as established in 32 states throughout the 
Southeast, South Central, and Midwest regions as well as along the eastern seaboard as 
far north as Maine (Springer et al., 2014). Its emerging geographic expansion and role as 
a vector of many important human disease agents makes A. americanum an important 
consideration in strategies to improve public health.  
With a lack of effective vaccines against TBD agents, the prevention of these 
infections in humans and animals depends on the control of ticks, which is currently 
acaricide based. However, acaricide use comes with many disadvantages, including the 
threat of food and environmental contamination and resistance development to these 
chemicals by ticks. A promising alternative strategy to the chemical control of ticks is to 
vaccinate hosts against the ticks themselves. The prerequisite to the development of an 
effective vaccine however, is the identification of effective molecular targets against tick 
feeding success and/or pathogen transmission. Among the emerging candidates for 
vaccine target antigens are members of the serine protease inhibitor (serpin) family.  
In animals, pathways critical to life, such as blood coagulation, complement 
activation, and inflammation are tightly regulated by serpins (Moore et al., 1993; 
Gettins, 2002; Tekin et al., 2005; Huntington, 2006, 2011; Gatto et al., 2013). 
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Furthermore, dysfunctional serpin activity in humans has been cited to cause numerous 
diseases including cirrhosis, emphysema, blood coagulation disorders, and dementia 
(Stein and Carrell, 1995; Davis et al., 1999; Gooptu and Lomas, 2009; Mocchegiani et 
al., 2011; Benson and Wilkes, 2012; Bosche et al., 2012; Gatto et al., 2013). The tick 
feeding style of lacerating host tissue and imbibing host blood which bleeds into the 
feeding site, is expected to provoke tissue repair and immune response mechanisms such 
as platelet aggregation, inflammation, blood clotting, and complement pathways 
(Ribeiro, 1989; Wikel et al., 1994), all of which are serpin-regulated. Thus, to complete 
feeding, ticks have to overcome serpin-regulated host defense pathways. From this 
perspective, itis conceivable that ticks may utilize serpins to block these host defenses 
against tick feeding (Mulenga et al., 2001, 2002).  
Serpin-encoding cDNAs have now been cloned from several tick species (Nene 
et al., 2002; Sugino et al., 2003; Mulenga et al., 2003a,b; Imamura et al., 2005, 2006; 
Ribeiro et al., 2006; Prevot et al., 2007; Chalaire et al., 2011; Yu et al., 2013). On the 
basis of unique putative functional domain reactive center loops (RCLs), at least 45 
serpins are expressed in I. scapularis (Mulenga et al., 2009). Similarly, Mulenga et al. 
(2007) and Karim et al. (2011) have reported at least 17 and 32 different serpin 
transcripts expressed in A. americanum and A. maculatum, respectively. Data are now 
emerging which support the idea that some tick-encoded serpins are functional inhibitors 
associated with counter defense against anti-tick responses in the host, such as 
inflammation, complement activation, platelet aggregation, and blood clotting (Imamura 
et al., 2005; Prevot et al., 2009; Chmelar et al., 2011, 2012; Mulenga et al., 2013a, b). In 
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other studies, a significant reduction in feeding efficiency has been observed in ticks 
which fed on animals immunized with recombinant tick serpins (Imamura et al., 2005, 
2006, 2008; Prevot et al., 2007; Kaewhom et al., 2009; Jittapalapong et al., 2010) 
suggesting a prime importance of serpins in tick feeding physiology. 
An observation in our lab is that while overall amino acid conservation levels for 
serpins are around 35–45%, there are some serpins which show much higher 
conservation across all tick species investigated. We believe that highly conserved 
serpins could play crucial role(s) in tick physiology. The goal of this study was two-fold: 
first, to identify serpin transcripts expressed in unfed and fed A. americanum ticks, and 
second, to conduct a global intra- and inter-tick species bioinformatic analysis of A. 
americanum serpins (AAS) and other tick serpins. This study has described 57 and 33 
AAS sequences that were respectively found only in male and female ticks, and a further 
30 that were found in both. Nearly half of the serpin sequences expressed in A. 
americanum are predicted to regulate pathways important to all tick species, as they 
show 58–97% amino acid conservation in both metastriate and prostriate ticks. Although 
this study is descriptive, data presented here provide a foundation for further in depth 
studies on the roles of serpins in tick physiology. 
Materials and Methods 
Identification and sequence analysis of A. americanum  serpin (AAS) transcripts 
AAS sequences used in this study were obtained by data mining of de novo assembled 
A. americanum  transcriptomes (unpublished data), serendipitously while attempting to 
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clone other targets, and from GenBank (Mulenga et al., 2007). A. americanum 
transcriptomes were assembled from Illumina sequence reads (BioProject accession 
number PRJNA226980) of 24 and 96 h fed female phage display cDNA expression 
libraries, unfed and fed male and unfed and 24 h fed female whole ticks, as well as 48, 
96 and 120 h fed tick dissected salivary gland (SG) and midgut (MG) tissues, using two 
approaches. In the first approach libraries were individually assembled with source 
library information for each contig retained, and in the second approach reads from all 
sources were combined and assembled (unpublished). Mining and identification of 
putative AAS sequences was accomplished in two steps. In the first step, assembled 
contigs were subjected to batch BLASTX screening against tick sequences in GenBank. 
In the second step, contig sequences with matches to serpin sequences were manually 
inspected to confirm the presence of two consensus amino acid motifs: the reactive 
center loop (RCL) “p17 [E]-p16 [E/K/R]-p15 [G]-p14 [T/S]-p13 [X]-p12-9 [AGS]-p8-1 
[X]-p1-4” in the C-terminus, and the ‘NAVYFKG’ motif in the N terminus (Carrell et 
al., 1987; Miura et al., 1995; Gettins, 2002). Sequences with a unique RCL sequence 
were identified as new and assigned an AAS number. Sequences without an RCL region 
were declared partial in the C-terminus region. For these sequences, two comparisons 
were made using Bl2seq-BLASTP (NCBI). First, these sequences were compared to 
each other to cluster contigs representing the same serpin. Next, we compared these 
clusters to AAS containing an RCL to eliminate redundancy between these groups. In 
addition to consensus amino acid motifs and secondary structure, a typical serpin ranges 
from 350 to 450 amino acids long (Gettins, 2002). Thus, sequences that had a starting 
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methionine and were at least 350 amino acid residues long were considered putatively 
full-length. Full-length sequences were subjected to SignalP Version 4 web server to 
detect signal peptides (Petersen et al., 2011). 
Relative AAS transcript abundance 
To get insight into relative abundance, Illumina reads were mapped back to 
assembled contigs using the map reads to reference option in CLC genomics workbench 
version 6.4.2. Relative abundance values were adjusted to account for contig size and 
total library reads using the following equation: eY = (nYNXL1X/nXNYLY) × eX, 18 
where eX and eY represent normalized relative abundance levels of AAS transcript in 
libraries X and Y, NX and NY represent the total number of reads in libraries X and Y, 
nX and nY represent the number of reads related to the specific AAS transcript in 
libraries X and Y, and LX and LY represent the length of the contig related to the 
specific AAS transcript in libraries X and Y. 
Phylogeny and comparative sequence analysis among AAS sequences 
To determine relationships between AAS sequences, a guide phylogeny tree was 
constructed using the neighbor-joining method in MacVector version 12 DNA analysis 
software (MacVector Inc., Cary, North Carolina). Sequences were first aligned using T-
coffee, then a phylogeny tree out-rooted from human antithrombin (CAA48690), was 
constructed using the neighbor-joining method set to the default bootstrap setting of 
1000 replications and differences adjusted using the absolute # differences setting. 
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Subsequently, AAS sequences that clustered together on the phylogeny tree were 
subjected to pairwise sequence alignment analyses using MacVector. For partial 
sequences, amino acid identity levels were determined based on available sequences. 
Comparative analyses of AAS to other tick serpin sequences 
To investigate relationships among all available tick serpins, AAS and other tick 
serpins from publically available databases were subjected to phylogeny analysis and 
multiple sequence alignment analyses using alignment tools at NCBI and MacVector 
version 12. This analysis was done at the whole amino acid sequence and RCL levels. At 
the whole amino acid sequence level, amino acid sequences were subjected to batch 
pairwise comparisons using Bl2seq-BLASTP (NCBI) to identify AAS orthologs in other 
tick species. The serpin RCL is an important functional domain, which determines what 
protease is regulated by a candidate serpin. Thus, to investigate the relationship of AAS 
sequences with other tick serpins at the functional level, the neighbor-joining method in 
MacVector (MacVector Inc.), was used to construct guide phylogeny trees using 
putative RCLs. To manage the huge dataset, RCLs were first divided into four groups 
based on charge and polarity characteristics of the amino acid residue at the putative P1 
site: polar basic, polar acidic, polar uncharged, and hydrophobic. A separate tree was 
constructed for each group. Next intra-clade pairwise alignments of RCLs were 
performed using MacVector to determine identity levels. 
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Results 
Amblyomma americanum male and female ticks express large numbers of serpin 
transcripts 
Data mining of transcriptomes from fed and unfed male and female whole ticks, 
as well as dissected 48, 96 and 120 h female SG and MG transcriptomes, identified 28 
and 57 AAS sequences respectively found only in females and males, respectively, and 
an additional 30 found in both (Table 1). Mulenga et al. (2007) described 17 AAS (here 
after identified as AAS1–17) sequences that were expressedin120h fed ticks. Of these 17 
AAS sequences, this study found 7 sequences in both males and females, and five AAS 
sequences in females, while the remaining five were not found at all. Taken together, 
these studies show the total number of AAS sequences found only in female ticks to be 
33 (Table 1). Please note that AAS 77 and 78 were found only in the combined A. 
americanum transcriptome were source library information for assembled contigs was 
not retained, and thus source information is unknown. Overall, 87 and 63 AAS 
sequences were found in male and female ticks, respectively. Assignment of AAS 
identification numbers was done arbitrarily in three steps. In the first step, assembled A. 
americanum transcriptomes were subjected to batch BLASTX scanning against tick 
serpin sequence entries at NCBI. This analysis identified 388 contigs that encoded 
putative serpins. A typical serpin is characterized by a unique RCL region (Gettins, 
2002). Thus in the second step, we conducted a manual inspection of all 388 contigs and 
found 61 previously unknown AAS RCL sequences that did not show identity to 
previously described AAS1–17 (Mulenga et al., 2007). AAS sequences
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Table 1: Updated list of Amblyomma americanum serine protease inhibitor transcripts 
Table 1a: AAS sequences found in male ticks 
AAS# ID Accession# Comment AAS# ID Accession# Comment AAS# ID Accession# Comment 
44 51298-AAFM Partial 73 9903-AAFM Partial 95 39404-AAFM Partial 
46 Cluster 46 Partial 74 25484-AAFM Partial 96 40959-AAFM Partial 
48 Cluster 48 Full, NSP 75 26362-AAFM Partial 97 41223-AAFM Partial 
49 34700-AAUM Partial 79 1446-AAFM Partial 98 41535-AAFM Partial 
50 Cluster 50 Partial 80 11697-AAFM Partial 99 41587-AAFM Partial 
52 1447-AAFM Partial 81 2964-AAFM Partial 100 42502-AAFM Partial 
53 2068-AAFM Full, NSP 82 16896-AAFM Partial 101 43086-AAFM Partial 
55 Cluster 55 Partial 83 19557-AAFM Partial 102 47122-AAFM Partial 
56 5603-AAFM Full, NSP 84 19764-AAFM Partial 103 51931-AAFM Partial 
57 7054-AAFM Full, NSP 85 3838-AAFM Partial 104 52784-AAFM Partial 
58 9916-AAFM Full, NSP 86 4992-AAFM Partial 105 56624-AAFM Partial 
59 12570 AAFM Full, NSP 87 26648-AAFM Partial 106 58458-AAFM Partial 
60 13872 AAFM Full, NSP 88 27587-AAFM Partial 107 60174-AAFM Partial 
61 38562 AAFM Partial 89 31297-AAFM Partial 111 44923-AAUM Partial 
62 48164 AAFM Partial 90 33489-AAFM Partial 113 9412-AAFM Partial 
64 16123-AAFM Partial 91 34304-AAFM Partial 114 1445-AAFM Partial 
68 Cluster 68 Partial 92 36187-AAFM Partial 120 Multiple Partial 
70 5478 AAUM Partial 93 37787-AAFM Partial 121 Multiple Partial 
71 54612-AAFM Partial 94 38659-AAFM Partial 122 7341-AAFM Partial 
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Table 1: Continued. 
Table 1b: AAS sequences found in female ticks 
AAS# ID Accession# Comment AAS# ID Accession# Comment AAS# ID Accession# Comment 
1 PC Full, SP 15 PC Full, SP 42 27458-SG120 Partial 
2 PC Full, SP 16 PC Full, SP 43 25306-MG48 Partial 
3 PC Full, SP 17 PC Full, SP 45 6976-MG120 Partial 
4 PC Full, SP 19 Cluster 19 Full, SP 65 54692-AAUF Partial 
5 PC Full, SP 20 Cluster 20 Full, SP 69 22634-AAFF Partial 
6 PC Full, SP 22 Cluster 22 Partial 76 ^ Full, NSP 
7 PC Full, NSP 26 Cluster 26 Partial 109 Cluster 109 Partial 
8 PC Full, SP 29 Cluster 29 Partial 112 59401-AAUF Partial 
9 PC Full, SP 32 11832-MG120 Partial 115 42294-MG120 Partial 
10 PC Full, SP 36 Cluster 36 Full, NSP 116 40934-SG48 Partial 
11 PC Full, NSP 37 Cluster 37 Partial 117 38175-SG48 Partial 
12 PC Full, SP 38 14471-SG96 Partial 118 47325-SG48 Partial 
13 PC Full, SP 40 32557-SG96 Partial 
14 PC Full, SP 41 16611-SG120 Partial 
Table 1c: AAS sequences found in both male and female ticks 
AAS# ID Accession# Comment AAS# ID Accession# Comment AAS# ID Accession# Comment 
18 Cluster 18 Full, NSP 31 Cluster 31 Full, SP 63 Cluster 63 Partial 
21 Cluster 21 Full, SP 33 444-PL2 Partial 66 Cluster 66 Partial 
23 Cluster 23 Full, SP 34 Cluster 34 Full, NSP 67 Cluster 67 Full, NSP 
24 Cluster 24 Partial 35 Cluster 35 Partial 72 Cluster 72 Partial 
25 Cluster 25 Full, NSP 39 Cluster 39 Full, SP 108 Cluster 108 Partial 
27 Cluster 27 Full, SP 47 Cluster 47 Full, NSP 110 Cluster 110 Partial 
28 Cluster 28 Full, NSP 51 Cluster 51 Partial 119 Cluster 119 Partial 
30 Cluster 30 Full, SP 54 Cluster 54 Partial 
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Table 1: Continued. 
Cluster = AAS has more than one representative contig; Full = full length open reading frame, SP = signal peptide is present, 
NSP = no signal peptide; ^ = contig sequence was too short for GenBank submission (<200bp). 
Table 1d: AAS sequences with no source information 
AAS# ID Accession# Comment AAS# ID Accession# Comment 
77 ^ Partial 78 Clust1-1-153 Partial 
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encoding the 61 new RCLs were assigned the identifications of AAS18–78, according to 
the order in which they were discovered. 233 of the 388 contigs did not have RCL 
regions. These sequences were subjected to intra-contig comparisons using the bl2seq-
BLASTN function at NCBI. This analysis identified 44 contig sequences that encoded 
previously unreported AAS sequences and were designated as AAS79–122 (Table 1). 
This brought the total number of unique transcripts identified in this study to 105. A 
typical serpin molecule is 350–450 amino acids long (Gettins, 2002). On this basis, 40 of 
the 122 AAS sequences were determined to have complete open reading frames (ORF), 
as well as the consensus serpin amino-terminus motif (NAVYFKG), and the start 
methionine. Of the 40 AAS ORFs, 23 are predicted to have signal peptides (Table 1). 
Majority of female AAS transcripts expressed in fed salivary glands and midgut tissues 
Figure 1A–C summarizes the different AAS sequences found in MG and SG of 48, 96 
and 120h fed female ticks. Data previously reported for AAS1–17 are indicated with an asterisk 
in Figure 1A, and data for MG and SG at 120 h is taken from Mulenga et al. (2007). Of the 63 
AAS sequences found in female tick transcriptomes to date, 48 have been found in 48, 96, and 
120 h MG and/or SG. Of these 48, 10 and 12 AAS sequences were respectively found only in 
MG or in SG, while the remaining 26 were found in both (Figure 1A). This translates to a total 
of 36 and 38 different AAS sequences found in MG and in SG, respectively. Of the 36 AAS 
found in MG, seven (AAS1, 4, 7, 8, 21, 31, and 109) were found at all-time points, four (AAS27, 
28, 72, and 110) were found at both 48 and 96 h time points, and four (AAS19, 20, 22 and 43), 
one (AAS108), and 16   (AAS9–18, 23, 29, 32, 36, 45, and 115) were found at the 48, 96, 
or 120 h time points, respectively (Figure 1B). Likewise, of the 38 AAS found in SG 
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(Figure 1C), five (AAS7, 19, 21, 23, and 110) were found at all-time points, seven 
(AAS3, 9, 25, 27, 28, 31, and 39) were found at the 96 and 120 h time points, and five 
(AAS20, 36, 116, 117, and 118), five (AAS24, 26, 37, 38 and 40), and 12 (AAS1, 2, 5, 
8, 10–17, 41, and 42) were found in 48, 96, or 120 h SG, respectively. 
Relative AAS transcript abundance 
We successfully mapped reads back to de novo assembled AAS contigs. This 
analysis identified 20 of 122 AAS transcripts with variable sequence reads in different 
libraries (Figure 2A and B). For 8 (AAS25, 28, 39, 51, 66, 108, 110, and 119) of the 20 
AAS sequences, differences between sequence reads were minimal and we concluded 
that these apparently occurred in equivalent abundance in all libraries. Figure 2A 
summarizes differential abundance for ten (AAS19, 21, 23, 27, 29, 30, 31, 50, 54, 67, 
72, 121) in unfed and fed, male and female whole tick libraries. Of ten AAS detected at 
unfed and fed time points, five are more abundant in unfed ticks (AAS19, 30, 31, 54, and 
67), four are more abundant in fed ticks (AAS21, 29, 50, and 121), and one (AAS72) 
showed a mixed pattern with abundance in unfed females, but not in unfed males, and a 
transcript increase in fed male ticks (Figure 2A). It is also notable that AAS19, 21, 29, 
and 30 are abundant in female ticks, while AAS50, 67, and 121 are predominant in male 
ticks. Of the 31 AAS sequences summarized in Figure 1, we determined differential 
abundance in SG and MG for five transcripts, AAS19, 21, 23, 27, and 31 (Figure 2B), 
with differences for the remaining sequences being minimal to negligible. While AAS23 
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AAS109 
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Salivary gland Midgut 
Figure 1. Adult female A. americanum salivary gland (SG) and midgut (MG) 
expressed serpin (AAS) transcripts. (A) total AAS sequences found in MG and SG 
and both at all tested time points, (B) apparent temporal and spatial distribution of 
AAS transcripts found in MG (B), and SG (C). Please note that 17 previously 
characterized SG and MG expressed AAS transcripts [42] are not included here. 
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Figure 2. Relative abundance of A. americanum serpin (AAS) transcripts. 
Sequence reads were mapped back to de novo assembled contigs in different libraries. 
Relative abundance values in: (A) unfed (empty bars) and fed (black filled bars) male 
and female ticks, and (B) dissected 48–120 h salivary glands (SG) and midguts (MG) 
were calculated using the formula described in Materials and methods. 
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transcript abundance increases with feeding in both SG and MG, the remaining show an 
apparent dichotomous pattern. Transcripts for AAS19, 21, 27, and 31 are highest at the 
96 h time point, and lower at the 120 h time point in SG. In MG, AAS19 and 21 are 
abundant at 48 h, and absent or low at 96 and 120 h time points, while AAS27 and 31 
increase with feeding (Figure 2B). 
A diversity of seventeen amino acid residues is predicted at P1 sites of AAS putative 
RCLs 
Table 2 lists 78 predicted reactive center loops (RCLs) from 27 (Table 2A) and 
22 (Table 2B) AAS sequences found in female and male ticks, the 27 found in both 
(Table 2C), and 2 of an undetermined source (Table 2D). Please note that Table 2A 
includes previously characterized AAS1–17 (Mulenga et al., 2007). We would like to 
note that the RCL regions for AAS68 and 71 (Table 2B), and AAS77 (Table 2D) are 
partial (marked with an asterisk in Table 2), however based on the available sequence we 
were still able to conclude these RCLs to be unique. Additionally, while the predicted 
RCL for AAS8 and 9, 4 and 12, and 13 and 15 are identical, these sequences differ in the 
N-terminus region by 13–25 amino acids (Mulenga et al., 2007). Numbering of amino 
acid residues in the RCL is based on the standard nomenclature developed by Schechter 
and Berger (1967), in which amino acid residues at the N terminal end of the scissile 
bond (P1–P1) are not primed and those on the C-terminal end are primed: ““p17 [E]-p16 
[E/K/R]-p15 [G]- p14 [T/S]-p13 [X]-p12-9 [AGS]-p8-1 [X]-p1-4” (Miura et al., 1995
38 
Table 2: Reactive center loops (RCLs) of A. americanum serpins 
Table 2A:  Predicted RCLs found in female ticks 
AAS ID        RCL amino acid sequence AAS ID          RCL amino acid sequence 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
EEGTVAAGVTSVRVKQKHSAR 
EEGTVAAGVTSVRVKPKSFAR 
EEGTGAAGVPSVGGKPKSFAR 
EEGTIAAAVTGLSFVPISALH 
EEGTVAAAVTGLSVTPLVVPP 
EEGTVATAVTGISLALSALHT 
EEGTEAAAATGIAMMLMCARF 
EEGSQAAAVTGVIIYTQSAFV 
EEGSPATAVTGVIMYTQSAFV 
EEGSQAAAVTGVIIYTQSAFV 
EEGTVPTAVPGILLVGLVARH 
EEGTIAAAVTGLSFVPISALH 
EEGTVAAAVTGLSFPHLVVPP 
EEGTVATAVTGISLVALSALH 
EEGTVAAAVTGLSFPHLVVPP 
EEGTAAEAVTGLSITPLAVPP 
EEGTVAAAVTGLSSIALSSVG 
19 
20 
22 
26 
29 
32 
36 
37 
38 
40 
41 
42 
43 
45 
65 
69 
76 
EEGSEAAAVTGFVIQLRTAAF 
EVGTRAVAATEAQFVSKSLVH 
EEGSEAAGATGVIFYTKSAIV 
EEGTEAAAATATVAMFGSAPS 
EEGTEAAAATAVTVVDGCMPR 
EDGTEPEVAPTNAVFQPAVRT 
EEGTEAAAATGMRIQLKTRVK 
EEGTEAAAATAVVMMCRSAAM 
EEGTIATAVTGLSFAPISALH 
EKGRAAAGVAARAFYTRAGDH 
EEGSEAAGATGVVFVELIAVR 
EKGTEAAAATAVMMMACCMSA 
EDGTEPEAAATNAVFQPAVRT 
EEGTEAAAATGVVMMCDSLPM 
EEGSETDSATLMRISGKAXCE 
EEGTIAAAVTGLSFVATASFN 
EEGTIAAAVTGSLFRAHLGSP 
Table 2b:  Predicted RCLs Found in male ticks 
AAS ID        RCL amino acid sequence AAS ID         RCL amino acid sequence 
44 
46 
48 
49 
50 
52 
53 
55 
56 
57 
58 
EEGTEAAAATAIITTECCIMP 
EEGSEAAGATGVIFVETIAVR 
EEGTEAAAGSASILTRRDAVE 
EDGTDSEAARANEVPEPAFSI 
EEGSETDSATLMRISGKAAEE 
ENGTVAAAASAAIGVGSAGPS 
EGGTEPGPATAGEASAPAGPE 
ENGTVAAAATAAEGGSSSGIM 
EEGLGEACRPPNPLPATMIAF 
ENGTGAPAAEGSIYSPAFRRR 
EEGTEAAAATGMTLMMCGAMV 
59 
60 
61 
62 
64 
68 
70 
71 
73 
74 
75 
EEGSWPVTYTEHVLSTGDPVT 
ENGSSAAAVTGTTLHKSVHVP 
EGGTDASSATAMTSLACSATM 
EEGTEPEAATANALIESAGSI 
ARGGRAVSNEVQSTTSATTAA 
EDGTVAASTAALAFHADRPF* 
EEGTIATAVTGLSFVATASFN 
EVGTKA* 
GAGGRPPSSNDSREAGTSPAK 
ERSTSRMPKYTGAQGAPGTSS 
RRGPKTVAAQAVAKEAARTAK ____________________________________________________________________
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Amino acid residues at putative P1 site are bolded; * indicates a partial RCL 
sequence. 
Gettins, 2002). Molecular analysis predictions of the P1 site assume that there are 17 
amino acid residues between the beginning of the RCL hinge region (P17), and the 
scissile bond (P1–P1’), (Hopkins and Stone, 1995). Based on these conventions, a 
diversity of 17 different amino acid residues is predicted at the P1 sites of AAS1–78 
(except for AAS71 which has a partial RCL excluding the P1 site, Table 2B). The P1 
residues for AAS1–78 have the following charge and polarity properties: 27 (∼35%) are 
polar uncharged [S (10/26), C (5/26), T (6/26), Q (4/26), Y (2/26)], 25 (∼32%) are 
hydrophobic [L (8/25), I (4/25), P (5/25), G (3/25), M (1/25), A (3/25), V (1/25)], 21 
(27%) are polar basic [R (11/21), K (9/21), H (1/21)], and four residues (∼5%) are polar 
acidic [D (3/4), E (1/4)] (Figure 3). It is noteworthy that 11 of the 22 AAS sequences 
found in MG and SG have basic residues at the predicted P1 site. 
Table 2: Continued. 
Table 2c: Predicted RCLs found in both male and female ticks 
AAS ID RCL amino acid sequence AAS ID RCL amino acid sequence 
18 
21 
23 
24 
25 
27 
28 
30 
31 
33 
EEGSEAAGATAVIFFTRGGSS 
EKGTEAVALSSGIIRHSKTPG 
EEGTVAAAVTSIRMRMKSSRR 
EEGTVATAVTGLSFVATASFN 
EEGTEAAAATAVVMMCYSLPM 
EEGTEAAAASGVVGVNRIGID 
EEGTEAAAATGMVAMARCAII 
EEGTVATAVTGLSNTRILDDS 
EEGSEAAAVTGVVINTRTIGG 
ENGTVAAAASAALLVGSAGPN 
34 
35 
39 
47 
51 
54 
63 
66 
67 
72 
ENGTKAAAATTALGSNSFYVP 
EKGTVAAASAAAAGGSSLYNP 
EKGTVASASTVAIIVSRIGTP 
EEGTEAAAATAMPAANSCEMF 
EEGTEAAAATAIIATECCIMP 
EDGVEGLFLTPLIMMCYAGVS 
EDGNEIARTSALVTEVVSKVA 
EKGRAAAGVAARTFYTRAGDH 
EEGSEAAAATAVLIETRSDVP 
EEPVRLDLHVSTLRLAERTDL 
Table 2d: Predicted RCLs, source undetermined 
AAS ID RCL amino acid sequence AAS ID RCL amino acid sequence 
77 EEGSQATAVTGVIIYTQS* 78 EEGTEAAAATSVVMMCDSLPM 
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Some AAS sequences are highly identical 
To gauge the relationships between AAS sequences, amino acid sequences were 
subjected to phylogeny analysis, except for AAS87 and 109, which were too short for an 
informative alignment (Figure 4). We would like to note that due to the large number of 
sequences, we split the tree into two parts, Figure 4P1 and P2. As shown in Figure 4, 68 
of the 122 AAS sequences segregated into 19 clusters labeled A–S, and the remaining 
sequences did not cluster. Of the 19 clusters, eight have more than two sequences: E 
(AAS8–10, 18, 22, 41, 46, and 67), F (AAS4–6, 11–17, 24, 30, and 112), G (AAS1–3, 
23), H (AAS75, 87, and 95), M (AAS32, 43, and 62), O (AAS33, 35, 52 and 79), P 
(AAS28, 36, 47, and 108), and R (AAS7, 25, 26, 37, 45, and 78), and the remaining 11 
clusters have single pairs. When subjected to pairwise sequence alignment analysis, 
sequences in clusters A, B, D, E, F, G, K, M, O, P, R, and S showed variable amino acid 
identity levels of 15, 96, 93, 66–98, 61–98, 40–93, 98, 84 (excluding AAS62), 66–98, 
56–78, 61–98, and 96%, respectively (Figure 4P1 and P2). In the remaining clusters 
(marked with asterisks), amino acid identity levels were below 15%. We would like to 
caution here that some sequences being compared are partial, and therefore the picture of 
these relationships might be incomplete. From pairwise alignment analyses, two general 
patterns emerged. In the first pattern, differences between two sequences were scattered 
throughout the alignment (not shown). In the second pattern, found between AAS25 and 
AAS45, and AAS33 and AAS52, differences were restricted to the C-terminus region 
within the RCL (not shown). 
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Figure 3. Diversity and counts for amino acid residues at the putative P1 position in reactive center loops of 
the first 78 A. americanum serpin sequences. Amino acid residues at putative P1 sites were determined based on 
molecular analysis predictions of the P1 site that assume that there are 17 amino acid residues between the 
beginning of the RCL hinge region (P17), and the scissile bond (P1-P1’).  
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A 
B 
C* 
D 
E 
F 
G 
% identity 
96% 
15% 
93% 
66-98% 
61-98% 
40-93% 
P1 
Figure 4. Relative abundance of A. americanum serpin (AAS) transcripts. Sequence reads 
were mapped back to de novo assembled contigs in different libraries. Relative abundance 
values in: (A) unfed (empty bars) and fed (black filled bars) male and female ticks, and (B) 
dissected 48–120 h salivary glands (SG) and midguts (MG) were calculated using the formula 
described in Materials and methods. 
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H* 
J* 
I* 
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O 
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Q* 
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98% 
84% 
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Figure 4. Continued. 
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Close to half of AAS sequences have orthologs in other tick species 
To determine if any AAS sequences in this study had orthologs in other tick 
species, inter-species comparisons were performed. A search for other tick serpin 
sequences in publically available databases retrieved 165 serpin sequences across nine 
tick species (Table 3). Pairwise comparisons of these serpins to AAS1–122 identified 50 
AAS sequences that were conserved in other tick species. To manage the high number of 
sequences, the data are presented in separate tables: A. americanum versus A. maculatum 
(Karim et al., 2011) and A. variegatum (Ribeiro et al., 2011) (Table 4A), and versus R. 
pulchellus (direct submission), R. appendiculatus (Mulenga et al., 2003b), R. microplus 
(Tirloni et al., 2014), The Gene Index Project, http://compbio.dfci.harvard.edu/tgi/],  R. 
haemaphysaloides (direct submission), H. longicornis (Imamura et al., 2005), I. 
scapularis (GenBank direct submissions, The Gene Index Project), and I. ricinus 
(Leboulle et al., 2002b) (Table 4B). As shown in Table 4A, AAS4–6, 8–19, 22–27, 29, 
30, 41, 46, and 47 show ≥75–96% amino acid identity to A. maculatum serpin sequences 
AEO35533, AEO35520, AEO34312, AEO34447, AEO34313, AEO34314, AEO32541, 
AEO34349, AEO34279, AEO34218, AEO34217, AEO33019, and AEO32217, while 
the remaining sequences showed  <75% amino acid conservation. Likewise, in Table 4b, 
AAS19–22, 41, 42, and 65 show amino acid identities of ≥75–91% to 7 R. 
pulchellusserpins: JAA54307, JAA54309, JAA543410, JAA54167, JAA54314, 
JAA54313, respectively, while the rest showed amino acid identities of <75%. 
Additionally, AAS7 shows 75 and 77% identity to R. microplus EST89704 and R. 
pulchellus JAA54312, and AAS19 and 21 show 82–96% identity to R. 
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Table 3: Other tick serpins downloaded from publically available databases 
Source tick species Accession# Source tick species Accession# Source tick 
species 
Accession# 
Amblyomma 
maculatum 
AEO35533 
R. microplus 
AHC98664 
I. scapularis 
TC36982 
AEO35320 AHC98665 TC38196 
AEO34447 AHC98666 TC40138 
AEO34349 AHC98667 TC40197 
AE034314 AHC98668 TC40226 
AE034313 AHC98669 TC40411 
AE034312 AAP75707 TC40562 
AE034279 TC16456_2 TC40843 
AE034218 EST767976_2 TC40980 
AE032154 EST896705_3 TC41916 
AE032160 ADK62395 TC48141 
AE032217 ADK62396 TC50198 
AE032541 
Ixodes ricinus 
ABI94058 XP_002402925 
AE032759 JAA66227 EW874987 
AE032774 JAA66279 DN974443 
AE033019 JAA66964 EW860426 
AE034217 JAA67593 XP_002416236 
A. variegatum 
DAA34267 JAA67756 XP_002415307 
DAA34257 JAA69032 XP_002407493 
DAA34183 JAA71154 XP_002399564 
DAA34478 JAA71155 XP_002435393 
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Table 3: Continued 
Source tick species Accession# Source tick species Accession# Source tick species Accession# 
Haemaphysalis 
longicornis 
BAD11156 JAA71156 
I. scapularis 
XP_002434763 
JAA72548 EW869079 
Rhipicephalus 
haemaphysaloides 
AFX65224 gi|310689892 XP_002434444 
AFX65225 gi|310689891 XP_002433376 
R. appendiculatus 
AAK61377 JAA71163 XP_002415208 
AAK61378 JAA66228 XP_002413438 
AAK61376 JAA73759 XP_002416263 
AAK61375 JAA72989 XP_002411933 
R. pulchellus 
JAA63611 JAA72940 XP_002411931 
JAA63258 JAA72595 XP_002402370 
JAA54387 EW949864 XP_002411045 
JAA54315 
I. scapularis 
EW837780 XP_002401187 
JAA54314 EW881762 XP_002400954 
JAA54313 EW901007 XP_002403236 
JAA54312 EW814209 XP_002401986 
JAA54311 EW860426 XP_002415891 
JAA54310 EW882018 XP_002415890 
JAA54309 ISCW017295 XP_002415888 
JAA54308 ISCW011017 XP_002415887 
JAA54307 ISCW024435 XP_002415886 
JAA54306 ISCW006062 XP_002415308 
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Table 3: Continued 
Source tick species Accession# Source tick species Accession# Source tick species Accession# 
R. pulchellus 
JAA54167 
JAA53966 
I. scapularis 
ISCW023208 
ISCW024387 
ISCW023617 
ISCW024109 
ISCW023621 
ISCW010422 
EW851734 
EW959899 
EW955724 
AAM93649 
AAV80788 
ACI446630 
TC36450 
TC54356 
I. scapularis 
XP_002416681 
XP_002416635 
XP_002408111 
XP_002416150 
XP_002415892 
XP_002411932 
XP_002402368 
XP_002399745 
XP_002405749 
ABJB011030283 
ABJB010229324 
ABJB011108013 
R. microplus 
AHC98652 
AHC98653 
AHC98654 
AHC98655 
AHC98656 
AHC98657 
AHC98658 
AHC98659 
AHC98660 
AHC98661 
AHC98662 
AHC98663 
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microplus TC17409, TC22658, and EST767976, while AAS41, 42, and 54 show 65, 79 
and 90% identity to partially characterized R. appendiculatus AAK61378, 
and AAK61376, and R. microplus TC16456, respectively. Four AAS (24, 38, 69, and 
70) showed 70% or greater identity to the same partially characterized R. appendiculatus
AAK61377. Of the 50 AAS sequences conserved in other tick species, only 11 
sequences (AAS19–21, 25, 37, 42, 44, 45, 54, 66 and 78) appear to be conserved in 
prostriate ticks (4b). Except for AAS19, which showed 81 and 82% amino acid identity 
to I. ricinusABI94058 and I. scapularisXP_00245308, respectively, all other AAS 
sequences showed 58–70% conservation with prostriate tick sequences (b). 
Table 5 summarizes the 29 AAS RCL sequences which show at least 62% 
sequence conservation in other tick species. Preliminary manual inspection of RCLs 
showed high identities between sequences where the predicted P1 site is of the same 
charge and polarity, therefore all 212 tick serpin sequences for which an RCL could be 
determined were first divided into one of the four groups: polar uncharged, polar basic, 
polar acidic, and hydrophobic. RCL sequences (Figure 5) were then subjected to 
phylogeny analysis (not shown). Lastly, RCLs from all tick species were subjected to 
pairwise sequence alignments. Identity levels for the 29 highly conserved AAS RCLs, 
(AAS4, 7, 12, 14, 18–23, 25–29, 31, 37, 38, 42, 44, 45, 47, 50, 52, 54, 58, 65, 69, and 
70) ranged from approximately 62–100% (Table 5). Of these 29 RCLs, seven (AAS7,
19–21, 23, 27, and 42) are conserved in both metastriate and prostriate ticks, with the 
remaining being conserved only in metastriate ticks. Seven AAS RCLs (AAS18, 20–22, 
27, 42, and 50) showed 95–100% conservation with at least one RCL from another 
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Table 4a: A. americanum serpins (AAS) that have orthologs in other 
Amblyomma spp ticks 
AAS 
ID 
Other tick best 
match 
% 
ID 
AAS 
ID 
Other tick best 
match 
% 
ID 
1 Amac-AEO32759 71 
25 
Amac-AEO35533 
Amac-AEO35520 
Amac-AEO32774 
Amac-AEO32541 
Amac-AEO32217 
Amac-AEO32160 
Amac-AEO32154 
81 
76 
70 
63 
64 
67 
70 
2 Amac-AEO32759 71 
3 Amac-AEO32759 70 
4 
Amac-AEO34312 
Amac-AEO34279 
79 
89 
5 
Amac-AEO34312 
Amac-AEO34279 
75 
77 
6 
Amac-AEO34312 
Amac-AEO34279 
75 
82 
26 
Amac-AEO35533 
Amac-AEO35520 
Amac-AEO32774 
Amac-AEO32541 
Amac-AEO32217 
Amac-AEO32160 
Amac-AEO32154 
64 
64 
62 
77 
79 
62 
61 
7 
Amac-AEO35533 
Amac-AEO35520 
Amac-AEO32774 
Amac-AEO32541 
Amac-AEO32217 
Amac-AEO32160 
Amac-AEO32154 
87 
86 
72 
65 
66 
70 
71 
27 Amac-AEO34349 81 
28 Amac-AEO34314 62 
8 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
82 
64 
71 
29 
Amac-AEO35533 
Amac-AEO35520 
Amac-AEO32774 
Amac-AEO32160 
Amac-AEO32154 
62 
59 
67 
61 
65 
9 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
79 
62 
69 
30 
Amac-AEO34312 
Amac-AEO34279 
76 
76 
10 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
82 
64 
72 
36 Amac-AEO34314 59 
37 
Amac-AEO35533 
Amac-AEO35520 
Amac-AEO32774 
Amac-AEO32541 
Amac-AEO32217 
Amac-AEO32160 
Amac-AEO32154 
67 
65 
71 
70 
73 
68 
71 
11 
Amac-AEO34447 
Amac-AEO34313 
63 
69 
12 
Amac-AEO34447 
Amac-AEO34313 
78 
89 
13 
Amac-AEO34447 
Amac-AEO34313 
74 
78 
14 
Amac-AEO34447 
Amac-AEO34313 
74 
80 
41 Avar-DAA34478 73 
46 
Avar-DAA34478 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
73 
69 
76 
75 
15 
Amac-AEO34447 
Amac-AEO34313 
73 
77 
16 
Amac-AEO34447 
Amac-AEO34313 
72 
75 
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Table 4a: Continued 
AAS 
ID 
Other tick best 
match 
% 
ID 
 
AAS 
ID 
Other tick best 
match 
% 
ID 
17 
Amac-AEO34447 
Amac-AEO34313 
75 
79 
 47 Amac-AEO34314 79 
17 
18 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO34447 
Amac-AEO34313 
75 
79 
68 
76 
 
67 
Amac-AEO34313 
Amac-AEO33019 
70 
74  
18 
19 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO32217 
Amac-AEO34218 
68 
76 
91 
91 
 
 
 
19 
 
22 
Amac-AEO32217 
Amac-AEO34218 
Avar-DAA34478 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
91 
91 
71 
69 
74 
86 
 
 
 
22 
23 
Avar-DAA34478 
Amac-AEO34447 
Amac-AEO34313 
Amac-AEO33019 
Amac-AEO32759 
71 
69 
74 
86 
66 
 
 
 
 
24 
Amac-AEO34312 
Amac-AEO34279 
77 
86 
 
Amac = A. maculatum, Avar = A. variegatum, % amino acid identities are bolded 
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Table 4b: AAS amino acid identity to serpins in metastriata and prostriata ticks 
AAS ID Other tick best match  % ID  AAS ID Other tick best match % ID AAS ID Other tick best match %ID 
1 
Rhaem-AFX65224 
Rapp-AAK61377 
Rmic-AAP75707 
Rmic-TC16466 
61 
69 
68 
73 
25 
Rapp-AAK61377 
Rapp-AAK61375 
Rmic-TC24850 
Rmic-EST89704 
Rpulc-JAA54306 
Rpulc-JAA54314 
Rpulc-JAA54313 
Rpulc-JAA54312 
Rpulc-JAA54311 
Ir-CAB55818.2 
Is-XP_002434444 
Ir-00245308 
Ir-EW874987 
66 
62 
66 
69 
70 
63 
66 
71 
64 
61 
59 
70 
70 
45 
Rpulc-JAA54306 
Rpulc-JAA54314 
Rpulc-JAA54313 
Rpulc-JAA54312 
Ir-XP_02399745 
Ir-XP_002408111 
66 
71 
71 
68 
61 
60 
4 
Rhaem-AFX65224 
Rapp-AAK61377 
Rmic-AAP75707 
Rmic-TC16466 
Hlong-BAD11156 
59 
66 
65 
67 
73 
46 
Rapp-AAK61378 
Rpulc-JAA54312 
64 
73 
47 
Rpulc-JAA63611 
Rpulc-JAA62387 
59 
60 
6 
Rapp-AAK61377 
Rmic-AAP75707 
Rmic-TC16466 
Hlong-BAD11156 
68 
66 
69 
69 
50 Rpulc-JAA54309 76 
54 
Rmic-TC16466 
Is-XP_002401187 
90 
58 
7 
Rhaem-AFX65224 
Rmic-TC24850 
Rmic-EST89704 
Rpulc-JAA54306 
Rpulc-JAA54314 
Rpulc-JAA54313 
Rpulc-JAA54312 
Hlong-BAD11156 
74 
69 
75 
72 
69 
69 
77 
74 
26 
Rmic-TC24850 
Rmic-EST89704 
Rpulc-JAA54306 
Rpulc-JAA54314 
Rpulc-JAA54313 
Rpulc-JAA54312 
Rpulc-JAA54311 
61 
61 
61 
66 
63 
62 
66 
65 Rpulc-JAA54309 80 
66 
Rpulc-JAA54310 
Is-XP_002415891 
70 
59 
67 Rpulc-JAA54310 68 
69 
Rapp-AAK61377 
Rmic-AAP75707 
Hlong-BAD11156 
70 
70 
68 
29 
Rmic-TC24850 
Rmic-EST89704 
Rpulc-JAA54310 
60 
62 
74 
70 
Rapp-AAK61377 
Rmic-AAP75707 
Hlong-BAD11156 
71 
71 
73 8 Rpulc-JAA54310 68 
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Table 4b: Continued 
AAS ID Other tick best match  % ID AAS ID Other tick best match % ID AAS ID Other tick best match %ID 
9 Rpulc-JAA54310 66 
10 Rpulc-JAA54310 66 
30 
Rapp-AAK61377 
Rmic-AAP75707 
Rmic-TC16466 
Hlong-BAD11156 
66 
66 
68 
70 
78 
Rpulc-JAA54306 
Rpulc-JAA54313 
Rpulc-JAA54312 
Rpulc-JAA54314 
Rmic-AHC98652 
Rmic-AHC98653 
Rmic-AHC98662 
Rapp-AAK61376 
Rhaem-AFX65225 
Is-XP_00240811 
Is-XP_002399745 
Ir-JAA66228 
Ir-JAA72595 
Ir-JAA66227 
65 
61 
70 
63 
62 
68 
61 
61 
68 
61 
61 
61 
61 
61 
11 
Rmic-TC16466 
Hlong-BAD11156 
62 
62 
12 
Rmic-TC16466 
Hlong-BAD11156 
72 
74 
36 
Rpulc-JAA63611 
Rpuc-JAA62387 
69 
68 13 Rmic-TC16466 67 
14 Rmic-TC16466 70 
37 
Rmic-EST89704 
Rpulc-JAA54306 
Rpulc-JAA54306 
Rpulc-JAA54314 
Rpulc-JAA54313 
Rpulc-JAA54312 
Rpulc-JAA54311 
Ir-CAB55818.2 
Is-ACI46630 
65 
63 
60 
67 
64 
63 
67 
60 
61 
15 Rmic-TC16466 66 
16 Rmic-TC16466 66 
17 Rmic-TC16466 69 
18 Rpulc-JAA54310 72 
19 
Rmic-TC22658 
Rmic-EST67697 
Rpulc-JAA54307 
Ir-ABI94058 
Is-XP_00245308 
95 
82 
87 
81 
82 
114 Rpulc-JAA54310 75 
38 
Rapp-AAK61377 
Rmic-AAP75707 
71 
70 
121 
Rpulc-JAA63611 
Rpulc-JAA62387 
67 
67 
20 
Rpulc-JAA54310 
Is-XP_002401986 
79 
58 39 Ir-XP_002401986 68 
21 
Rmic-TC17409 
Rpulc-JAA63258 
Ir-JAB72483 
Is-XP_002401986 
96 
91 
67 
70 
40 Rpulc-JAA54310 67 
41 
Rapp-AAK61378 
Rpulc-JAA54310 
65 
76 
53 
Table 4B: Continued 
AAS ID Other tick best match  % ID AAS ID Other tick best match % ID 
22 Rapp-AAK61378 61 
42 
Rapp-AAK61376 
Rpulc-JAA54314 
Rpulc-JAA54313 
Is-XP_002403236 
Is-XP_002407493 
79 
79 
77 
61 
61 
23 
Rhaem-AFX65224 
Rpulc-JAA54310 
71 
75 
24 
Rapp-AAK61377 
Rmic-AAP75707 
Rmic-TC16466 
71 
71 
73 
44 
Rpulc-JAA54314 
Ir-XP_02399745 
59 
58 
Rapp = R. appendiculatus, Rmic = R. microplus, Rhaem = R. haemaphysaloides, Rpulc = R. pulchellus, Ir = I. ricinus, Is = I. 
scapularis, and Hlong = H. longicornis. % amino acid identities are bolded 
Table 5 Cross-tick species conserved A. americanum serpin reactive center loops 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
AAS4* EEGTIAAAVTGLSFVPISALH - AAS26 EEGTEAAAATATVAMFGSAPS - 
Amac-AE034279 EEGTIATAVTGLSFVALSALS 81 Amac-AE032541 EEGTEAAAATAVIMVFGSASS 76 
Rapp-AAK61377 EEGTIATAVTGLGFVPLSAHY 76 Amac-AE032217 EEGTEAAAATAVIMLFGSASS 76 
Rmic-AAP75707 EEGTIATAVTGLGFVPLSVHY 71 AAS27 EEGTEAAAASGVVGVNRIGID - 
Rmic-AHC98654 EEGTIATAVTGLGFVPLSAHY 71 Is-EW860426 EEGTEAAAASGVVAVNRLIGV 66 
Rmic-AHC98661 EEGTVAAAVTGLFVRPTAPLP 71 Is-XP_002411045 EEGTEAAAASGVVMTRRAIEG 75 
Rmic-AHC98655 EEGTIAAAVTGLFVMPSSSLY 81 Amac-AE033019 EEGTQAAAASGVVGVNRIGIE 90 
Hlong-BAD11156 EEGTVATAVTGISFIPLSAHY 67 Rpulc-JAA54308 EEGTEAAAVSGVVSVNRIGIE 86 
AAS7 EEGTEAAAATGIAMMLMCARF - Rmic-AHC98657 EEGTEAAAVTGVIGVNRIGIE 81 
Amac-AE035320 EEGTEAAAATGMAFMLLSARF 81 AAS28 EEGTEAAAATGMVAMARCAII - 
Ir-JAA66227 EEGTEAAAATAIPIMLMCARF 86 Rmic-AHC98669 EEGTEAAAATGMVAMARCASM 90 
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Table 5: Continued 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
Ir-JAA72595 EEGTEAAAATAVPVMFCCAIF 66 AAS29 EEGTEAAAATAVTVVDGCMPR - 
Rhaem-AFX65225 EEGTEAAAATAITMMTYCARF 81 Rmic-AHC98662 EEGTEAAAATAVMMVACCMSS 71 
Rapp-AAK61376 EEGTEAAAATAITMMTYCARF 81 AAS31 EEGSEAAAVTGVVINTRTIGG - 
Rpulc-JAA54312 EEGTEAAAATAITMMTYCARF 81 Rmic-AHC98667 EEGSEAAAVTGVTINTRTTTG 81 
AAS12 EEGTIAAAVTGLSFVPISALH - Rmic-AHC98657 EEGTEAAAVTGVIGVNRIGIE 71 
Amac-AE034279 EEGTIATAVTGLSFVALSALS 81 AAS37 EEGTEAAAATAVVMMCRSAAM - 
Rapp-AAK61377 EEGTIATAVTGLGFVPLSAHY 71 Rpul-JAA54314 EEGTEAAAATAVMMMACCMSS 66 
Rmic-AAP75707 EEGTIATAVTGLGFVPLSVHY 71 Rmic-AHC98662 EEGTEAAAATAVMMVACCMSS 66 
Rmic-AHC98654 EEGTIATAVTGLGFVPLSAHY 71 Rmic-AHC98669 EEGTEAAAATGMVAMARCASM 71 
Rmic-AHC98661 EEGTVAAAVTGLFVRPTAPLP 71 AAS38 EEGTIATAVTGLSFAPISALH - 
Rmic-AHC98655 EEGTIAAAVTGLFVMPSSSLY 81 Amac-AE034279 EEGTIATAVTGLSFVALSALS 86 
Hlong-BAD11156 EEGTVATAVTGISFIPLSAHY 67 Rapp-AAK61377 EEGTIATAVTGLGFVPLSAHY 81 
AAS14 EEGTVATAVTGISLVALSALH - Rmic-AHC98654 EEGTIATAVTGLGFVPLSAHY 71 
Amac-AE034279 EEGTIATAVTGLSFVALSALS 81 AAS42 EKGTEAAAATAVMMMACCMSA - 
Rapp-AAK61377 EEGTIATAVTGLGFVPLSAHY 67 Rpulc-JAA54314 EEGTEAAAATAVMMMACCMSS 90 
Rmic-AAP75707 EEGTIATAVTGLGFVPLSVHY 62 Amac-AE032774.1 EKGTEAAAATAVMMVACCLSI 86 
Hlong-BAD11156 EEGTVATAVTGISFIPLSAHY Amac-AE032154.1 EKGTEAAAATAVMMVGCCLSI 81 
AAS18 EEGSEAAGATAVIFFTRGGSS - Rmic-AHC98662 EEGTEAAAATAVMMVACCMSS 86 
Amac-AE034313 EEGSEAAGATAVIFFTRGGIP 90 Rmic-AHC98652 EEGTEAAAATAVMMAACCLSS 81 
Avar-DAA34478 EEGSEAAGATAVIFFTRGGAP 90 Rapp-AAK61375 EEGTEAAAATAVMMAACCLSS 81 
Rmic-AHC98668 EEGTIAAAVTGLFVMPSSSLY 71 Is-XP_002405749 EEGTEAAAATAMVMLCCMSFP 76 
AAS19 EEGSEAAAVTGFVIQLRTAAF - AAS44 EEGTEAAAATAIITTECCIMP - 
Rpulc-JAA54307 EEGSEAAAVTGFVIQLRTAAF 100 Rmic-AHC98662 EEGTEAAAATAVMMVACCMSS 66 
Amac-AE034218 EEGSEAAAVTGFVIQLRTAAF 100 AAS45 EEGTEAAAATGVVMMCDSLPM - 
Amac-AE034217 EEGSEAAAVTGFVIQLRTAAF 100 Rmic-AHC98669 EEGTEAAAATGMVAMARCASM 71 
55 
Table 5: Continued 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
Serpin ID 
Conserved RCL amino acid 
sequence 
*% 
ID 
Ir-JAA72548 EEGSEAAAVTGFVIQLRTAAF 100 AAS47 EEGTEAAAATAMPAANSCEMF - 
Ir-ABI94058 EEGSEAAAVTGFVIQLRTAAF 100 Amac-AE034314 EEGTEAAAATAMLASNSCERF 86 
Is-XP_002415308 EEGSEAAAVTGFVIQLRTAAF 100 AAS50 EEGSETDSATLMRISGKAAEE - 
Rmic-TC22658 EEGSEAAAVTGFVIQLRTAAF 100 Rpulc-JAA54309 EEGSEADSATLLRISGKAAEE 90 
AAS20 EVGTRAVAATEAQFVSKSLVH - Rmic-AHC98660 EEGSEADSATLLRISGKAAEE 90 
Rpulc-JAA54167 EVGTRAVAATQAQFVSKSLVH 95 AAS52 ENGTVAAAASAAIGVGSAGPS - 
Is-ISCW016489 EEGTRAVAATQAQFVSKSLVQ 90 Rpulc-JAA54315 EEGTEAAAATAAVGAGSAGPS 76 
Rmic-AHC98664 EVGTRAVAATQAQFVSKSLVH 95 AAS54 EDGVEGLFLTPLIMMCYAGVS - 
AAS21 EKGTEAVALSSGIIRHSKTPG - Rmic-AHC98663 EDGVEGLFLTPLIMMCYAGVS 
10
0 
Rpulc-JAA63258 EKGTEAVALSSGIIRHSKTPG 100 AAS58 EEGTEAAAATGMTLMMCGAMV - 
Rmic-AHC98658 EKGTEAVALSSGIVRHSKTPG 95 Rmic-AHC98669 EEGTEAAAATGMVAMARCASM 71 
Is-XP_002401986 EQGTEAVALSSGIVRHSRPPE 95 AAS65 EEGSETDSATLMRISGKA-CE - 
Ir-JAB72483 EQGTEAVALSSGIVRHSRPPE 90 Rpulc-JAA54309 EEGSEADSATLLRISGKAAEE 81 
Rmic-AHC98658 EKGTEAVALSSGIVRHSKTPG 95 Rmic-AHC98660 EEGSEADSATLLRISGKAAEE 88 
AAS22 EEGSEAAGATGVIFYTKSAIV - AAS69 EEGTIAAAVTGLSFVATASFN - 
Amac-AE034349 EEGSEAAGATGVIFYTKSMVV 90 Rmic-AHC98661 EEGTVAAAVTGLFVRPTAPLP 71 
Rpulc-JAA54315 EEGSEAAAATAVIFYTKSAAV 86 AAS70 EEGTIATAVTGLSFVATASFN - 
Rmic-AHC98668 EEGTIAAAVTGLFVMPSSSLY 90 Rmic-AHC98654 EEGTIATAVTGLGFVPLSAHY 66 
AAS23 EEGTVAAAVTSIRMRMKSSRR - 
Amac = A. maculatum, Is = I. scapularis, Ir = I. ricinus, Rapp= R. 
appendiculatus, Rmic = R. microplus, Rpulc = R. pulchellus, Rhaem 
= R. haemaphyssaloides, Avar = A. variegatum, Hlong= H. 
longicornis. Amino acid residues at P1 sites are bolded. 
Is-XP_002434763 EKGTVAAAVTSISMRMGSSLA 76 
AAS25 EEGTEAAAATAVVMMCYSLPM - 
Rmic-AHC98653 EEGTEAAAATAVTLMTYCARI 66 
Rmic-AHC98662 EEGTEAAAATAVMMVACCMSS 66 
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A B
Figure 5. Multiple sequence alignment of tick serpin reactive center loops (RCL). 
Predicted RCLs in serpins found in this study and other tick serpins downloaded from 
GenBank were subjected to multiple sequence alignment using T-coffee in MacVector 
version 12. Asterisk (*) sign denotes predicted amino acid residues at P1 sites: (A) polar 
acidic, (B) polar basic, (C) hydrophobic, and (D) polar uncharged. Identical amino acid 
residues are shaded gray. AAS – Amblyomma americanum serpins, Amac – A. maculatum, 
Avar – A. variegatum, Rmic – Rhipicephalus microplus, Rpulc – R. pulchellus, Rhaem – R. 
haemaphysalis, Rapp –R. appendiculatus, Hlong – Haemaphysalis longicornis, Is – Ixodes 
scapularis, Ir – I. ricinus. 
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Figure 5. Continued.
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species. For AAS25, RCL identity to its partially characterized ortholog in R. 
appendiculatus (AAK61375), was higher, at 81% identity, than for whole sequence 
identity, at 62%. Three AAS RCLs (AAS7, 19, and 20) showed >80% identity to at least 
one RCL from a prostriate species. The identities between remaining RCL sequences 
ranged between ∼62 and 76% (Table 5). Itis notable that the RCL for AAS19 is 100% 
identical to serpin RCLs across several tick species in multiple genera, and including 
both metastriate and prostriate ticks. Of the 29 conserved AAS RCLs, 38% (11/29) 
(AAS18–20, 22, 23, 27, 28, 31, 37, 50, 65) have basic amino acid residues, 35% (10/29) 
(AAS21, 25, 42, 44, 47, 52, 54, 58, 69, and 70) have polar uncharged residues, and 24% 
(7/29) (AAS4, 7, 12, 14, 26, 29, 38, and 42)  have hydrophobic residues, while only one 
sequence, AAS45, has a polar acidic residue at the putative P1 site. It is interesting to 
note that for the 10 most highly inter-species conserved RCL sequences (those which are 
≥90%), the majority (7/10) have basic P1 residues, while the remaining three have polar 
uncharged P1 residues. 
Discussion 
This study provides an update of unique serpin-coding sequences expressed in 
unfed and fed A. americanum male and female ticks. While this is the first report of a 
very large number of serpin transcripts from male ticks, data presented here are not 
unusual. High numbers of serpin sequences were reported in ticks I. scapularis 
(Mulenga et al., 2009), R. pulchellus (direct submission), and A. maculatum (Karim et 
al., 2011), in mosquitoes Anopheles gambiae, Culex quinquefasciatus, and Aedes aegypti 
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(Rawlings et al., 2012), in Bombyx mori (Zou et al., 2009), Tribolium (Zou et al., 2007), 
Drosophila (Reichhart, 2005), in mouse and human genomes (Puente and López-Otín, 
2004; Gatto et al., 2013; Heit et al., 2013), and in Arabidopsis and Oryza sativa (Fluhr et 
al., 2012). Such large serpin counts across a great diversity of taxa indicate the 
importance of this protein family in regulating homeostasis in most branches of life. 
While serpin counts in other tick species do not approach the number for A. americanum 
as reported here, the discrepancy is likely due to the fact that this is the first analysis of 
tick transcriptomes of its scope with both male and female tissues at various time points 
having been explored. 
Although based on the design of this study we are unable to conclude expression 
patterns, the observation of a greater diversity of AAS transcripts in male than female 
ticks is interesting. We speculate that the high diversity of AAS transcripts found in male 
ticks could be explained by the timing of reproductive physiological changes. Male 
metastriate tick species such as A. americanum feed for only a short time prior to 
completion of spermatogenesis and mating (Kiszewski et al., 2001). On the other hand, 
many female reproductive activities including vitellogenin synthesis and deposition into 
oocytes, ovulation, fertilization, and oviposition do not occur until after several days of 
feeding (Kiszewski et al., 2001; Sonenshine and Roe, 2014). The majority of AAS which 
were found exclusively in males in this study, were from male ticks fed for at least three 
days and were potentially ready to mate, while female ticks in this study were fed up to 
120 h with reproductive activities just beginning. As a result, it is possible that there are 
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additional serpins important for female reproductive physiology that are expressed at 
later feeding time points than those identified in this study. 
Although empirical data will be needed, it is interesting to note that AAS50 and 
121 both found in male ticks were abundant after feeding when the male tick has entered 
its physiologically reproductive state. It will be interesting to investigate expression of 
serpins in the immature stages, where there is a lack of sexual dimorphism. This will 
inform on which serpins are indeed involved in sex-specific physiology, and which are 
involved in other feeding-related physiology such as host-defense modulation. Evidence 
in insects, Drosophila and Aedes aegypti, indicated that serpins are among the male 
reproductive gland proteins transferred to females during mating (Coleman et al., 1995; 
Sirot et al., 2008). Although there are distinct differences between biology of ticks and 
insects, it is plausible that some male A. americanum serpins found in this study could 
serve as reproductive proteins. The SG and MG represent two major organs through 
which the tick interacts with its host and with pathogens. Thus, the identification of 31 
previously unknown AAS transcripts in SG and MG is interesting. Although relative 
expression analysis done in this study is limited, the expression patterns of AAS21 and 
AAS27 are notable. Based on relative abundance determined in this study AAS21 
abundance is 1000-fold higher at 48 h MG compared to SG, while AAS27 increases 500 
fold at 120 h in MG more than SG. It will be interesting to investigate role(s) of AAS21 
and AAS27 in tick feeding. Another important goal of this study was to identify A. 
americanum tick serpins that are expressed in both male and female metastriata ticks. 
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We believe that these could represent those that are important to tick feeding regulation. 
Despite obvious differences in their biology, both male and female ticks must interact 
with host defense mechanisms before mating. Indeed, there is evidence that like females, 
male ticks express anti-inflammatory molecules such as histamine-binding proteins 
(Paesen et al., 1999; Bior et al., 2002), which are potentially involved in facilitating male 
tick feeding. Thus, the 16 AAS transcripts found in both male and female ticks, and in 
48–120 h SG and MG could represent those that are important to tick feeding success. 
The high number of AAS sequences in this study could be explained by gene 
duplication and exon shuffling in the RCL region as suggested by high amino acid 
identity among some AAS sequences that clustered together on the phylogeny tree and 
those that showed differences restricted to the RCL region. Serpin diversity by gene 
duplication and subsequent divergence has been reported in a number of organisms 
including humans (Heit et al., 2013), mice (Borriello and Krauter, 1990; Hancock, 2005) 
and B. mori (Zou et al., 2009). In An. gambiae serpin genes clustering phylogenetically 
were found in clusters on the same chromosome, indicating that they could be duplicated 
genes (Suwanchaichinda and Kanost, 2009). Similarly, in I. scapularis 11 highly 
identical serpins were found on the same supercontig (Mulenga et al., 2009). The 
observation of differences restricted to the RCL has been observed in transcripts that are 
products of alternatively spliced exons. This phenomenon was reported in Manduca 
sexta (Jiang and Kanost, 1997), in B. mori (Zou et al., 2009), and in Ctenocephalides 
felis (Brandt et al., 2004). We also observed a very curious pattern between AAS4 and 
12, and AAS13 and 15, in which RCLs were identical with differences restricted to 
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outside of the RCL (Mulenga et al., 2007). Whether or not these observations are 
consistent with events in vivo requires further investigation. However, itis interesting to 
note that in this study we observed a similar pattern between serpin sequences in other 
tick species: A. maculatum AEO34217 and AEO34218, and R. pulchellus JAA62387 
and JAA63611, where the RCL is the same and differences in sequences are outside of 
the RCL region. We speculate that if consistent with events in vivo, AAS transcripts that 
share the same RCL sequence could function as redundant proteins, or could regulate the 
same protease under different spatio-temporal conditions. 
Within the RCL region, the amino acid at the P1 site is considered most 
important in determining the target protease(s) that is/are regulated by a candidate serpin 
(Gettins, 2002; Huntington, 2006, 2011). Accordingly, the observation that 17 different 
amino acid residues were predicted at P1 sites of putative RCLs identified in this study 
indicates the potential diversity of proteases that may be regulated by these serpins. Our 
analysis of AAS RCL P1 sites showed a near-even distribution of residues across 
charge/polarity types with the exception of polar acidic similar to M. sexta, B. mori (Zou 
et al., 2009), plants (Roberts et al., 2004; Roberts and Hejgaard, 2008), and humans 
(Cassar and Hunter, 2013) where polar acidic P1 residues in serpins appear to be rare. 
Prediction of the P1 site amino acid residue is not in itself sufficient to determine the 
protease that may be regulated by a candidate serpin; empirical evidence is required. 
However, there is ample evidence that serpins with basic residues at the P1 site regulate 
trypsin and trypsin-like proteases (Gettins, 2002; Li et al., 1999; Leboulle et al., 2002a, 
b; Prevot et al., 2006). Thus it is interesting that the most highly conserved AAS RCLs 
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in this study have basic P1 residues. From the perspective of tick feeding biology, 
serpins with basic P1 residues could represent those that ticks use to evade trypsin-like 
protease-mediated host defense pathways such as blood clotting. We would like to 
caution the reader here that in both plants and in non-hematophagous organisms such as 
Drosophila, the majority of serpins have basic P1 amino acid residues (Reichhart, 2005; 
Fluhr et al., 2012). It is also interesting to note that two tick anti-coagulant serpins, 
HLS2 (orthologous to AAS12), in H. longicornis (BAD11156) (Imamura et al., 2005), 
and Iris in I. ricinus (AJ269658) (Prevot et al., 2006), contain hydrophobic residues at 
their P1 sites. Further experiments are therefore required in order to determine 
proteases/pathways that may be regulated by the serpins described in this study. 
In nature, different tick species may infest the same animal host and implicitly, 
these different tick species will face the same host defense mechanisms. It is conceivable 
that different tick species could utilize conserved proteins to interact with the same host, 
such as the 50 cross-tick species conserved AAS sequences identified in this study. It is 
notable that only ∼22% (11/50) were conserved in both metastriate and prostriate tick 
species. These could be particularly interesting candidates for further functional studies 
given that in general, amino acid identities between metastriate and prostriate tick 
proteins sequences are low. In particular, AAS25, which was detected in fed males and 
females, and in SG, is orthologous to Iris, found in SG and saliva of I. ricinus. Iris was 
demonstrated to inhibit lymphocyte proliferation, as well as the immune system 
cytokines IFN- and IL-6 (Leboulle et al., 2002a, b). Similarly, highly conserved AAS 
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proteins represent very interesting candidates for development of universal anti-tick 
vaccines as advocated (Maritz-Olivier et al., 2007). 
The RCL is important to serpin function (Gettins, 2002), and thus it is interesting 
to note that some AAS RCLs are 90–100% conserved in other tick species. These 
serpins could be involved in regulating target proteases that are important to all ticks. 
Based on our inter-species comparative sequence analysis, it is interesting to note that 
AAS sequences with polar basic P1 sites, followed by polar uncharged P1 sites, were 
likely to be conserved in other tick species. It is noteworthy that hydrophobic P1 
residues, though prevalent, tended to show little conservation in other tick species. This 
suggests that proteases that can interact with hydrophobic Pl residues may be involved in 
species-specific physiology, and might be diverging at a fast rate. Although the present 
study is descriptive, it contributes significantly to the picture of serpin transcript 
diversity expressed by male and female A. americanum ticks. Additionally, based on the 
data in this analysis, the picture of serpin transcript diversity in other tick species is 
likely to be far from complete. 
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CHAPTER III 
BIOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF AMBLYOMMA 
AMERICANUM SERINE PROTEASE INHIBITORS 4 (AAS4) and 8 (AAS8) 
 
Introduction 
 In Chapter II, bioinformatic analyses revealed that A. americanum expresses no 
less than 122 unique serpin sequences, 48 of which are expressed in salivary gland (SG) 
or midgut (MG) tissues (Porter et. al., 2015; Mulenga et. al., 2007). AAS4 and 8, 
originally named lospin 4 and 8 (GenBank ABS87356.1 and ABS87360.1), were first 
identified as being among 17 serpins that are expressed in female A. americanum during 
feeding: in SG and MG for AAS8 and in SG, MG, carcass (CA), and ovaries (OV) for 
AAS 4 (Mulenga et al., 2007). Additionally, bioinformatic analyses of transcriptome 
data in Chapter II shows AAS8 was found in MG 48h-, 96h-, and 120h- while AAS4 is 
expressed in SG 48h and in MG 48h-, 96h-, and 120h- post-tick attachment time points 
(Porter et al., 2015). AAS4 was also found in both unfed and fed ticks.  
 The SG and MG are important organs in tick feeding physiology. To feed, ticks 
insert their mouthparts into the host and lacerates the vascularture, stimulating the host 
blood coagulation and platelet formation cascades as diagramed in Figure 6. Products of 
the tick SG are involved in establishing the feeding site and injecting proteins involved 
in the counterdense of these host defences. The SG also participates in the elimination of 
excess water during feeding and is a passageway for tick-borne pathogens migrating 
from the tick to the host. The tick MG is a repository for imbibed host blood and  
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Figure 6. Diagram of vertebrate blood coagulation and platelet cascades. The 
diagram shows that a cascade of blood coagulation inhibitors results in the converstion 
of Prothrombin to Thrombin which converts fibrinogen to fibrin that covers platelets, 
reinforcing the clot. 
pathogens (Sonenshine and Roe, 2014). Thus, expression of AAS4 and AAS8 in both 
SG and MG suggested the potential for these two serpins to play a role in the physiology 
of tick feeding.  However, empirical analyses are needed to confirm this prediction. 
Most interestingly, BLASTP analysis in Chapter II revealed seven sequences 
from five other tick species with identity to AAS4 above 50% (Table 1). AAS4 was 79 
and 89% identical to A. maculatum AEO34312 and AEO34279, respectively. Outside of 
the Amblyomma genus, AAS4 was 65 and 67% identical to R. microplus serpins 
AAP75707.1 and TC16466. One ortholog was found in R. appendiculatus, serpin-3 
(AAK61377.1) with 70% identity, one in R. haemaphysaloides (AFX65224.1) with 59% 
identity, one in Haemaphysalis longicornis, serpin-2 (BAD11156) at 73% identity 
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(Porter et al., 2015). In this chapter, an updated BLASTP screen revealed four additional 
sequences from two tick species with identity to AAS4 above 50% (Table 1): R. 
microplus serpins RmS10 (AHC98661.1), RmS4 (AHC98655.1), and RmS3 
(AHC98654.1), at 64, 69, and 72% identity, respectively, and Haemaphysalis flava at 
74%. Likewise, BLASTP analysis in Chapter II revealed 4 sequences from 2 other tick 
species with identity to AAS8 above 50% (Table 1): 64, 71, and 82% for A. maculatum 
AEO34313, AEO33019, AEO34447, respectively, and 68% for R. pulchellus JAA54310 
(Porter et al., 2015). In this chapter, an updated BLASTP screen found four additional 
sequences from three tick species with identity to AAS8 at 50% or higher: R. microplus 
RmS17 (AHC98668) at 68%, R. appendiculatus serpin-4 (AAK61378) at 54%, and I. 
ricinus serpin-1 precursor (ABI94055) at 50% and serpin-2 precursor (ABI94056.2) at 
50%. Serpins with high amino acid conservation across tick genera are particularly 
interesting as potential candidates for inclusion in anti-tick vaccines because of the 
potential to have broad-spectrum activity against many tick species. One of the major 
limitations of the only successful anti-tick vaccine, Bm86, is that it has narrow tick 
species specificity (Sonenshine and Roe, 2014). 
Data are accumulating that support the idea that some tick-encoded serpins are 
functional inhibitors of exogenous proteases and are associated with counter-defense 
against anti-tick responses in the host, such as inflammation, complement activation, 
platelet aggregation, and blood clotting (Imamura et al., 2005; Prevot et al., 2009; 
Chmelar et al., 2011, 2012; Mulenga et al., 2013a, b). For example, Prevot et al., (2006) 
characterized a serpin in I. ricinus (Iris) ticks as an elastase inhibitor functioning in the 
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inhibition of coagulation, fibrinolysis, and platelet adhesion.  In another study, Iris was 
also characterized to bind monocytes/macrophages and to prevent these cells from 
secreting tumor necrosis factor-α (TNF-α) (Prevot et al., 2009). A second serpin from I. 
ricinus (IRS-2) from saliva was later characterized to inhibit cathepsin G and chymase, 
and to prevent neutrophil migration and cathepsin G- and thrombin-induced platelet 
aggregation (Chmelar et al., 2011). I. scapularis serpin 1E1 was characterized as a 
thrombin and trypsin inhibitor that affects blood clotting and platelet aggregation (Ibelli 
et al., 2014). 
In R. microplus, a serpin (Rmi-serpin) was characterized to inhibit trypsin 
(Rodriguez-Valle et al., 2011). Also in R. microplus, RmS-1 and -6 are chymotrypsin 
inhibitors, and RmS-3 is a chymotrypsin and elastase inhibitor (Rodriguez-Valle et al., 
2015). R. microplus serpin 15 (RmS-15) was characterized as a physiological thrombin 
inhibitor that prolongs plasma clotting time (Xu et al., 2016). Yu et al., (2013) described 
R. haemaphysaloides serpins 1 and 2 (RHS-1 and -2) as chymotrypsin inhibitors and 
inhibitors of blood coagulation as assayed in the activated partial thromboplastin time 
(aPTT) assay. A. americanum serpin 6 (AAS6) was described as having cross-class 
inhibitory properties against trypsin, chymotrypsin, chymase, and elastase serine 
proteases, as well as the cysteine protease papain (Mulenga et al., 2013b). This serpin 
prolonged plasma clotting time and displays inhibitory properties in platelet aggregation. 
Another A. americanum serpin, AAS19, was characterized as a trypsin, plasmin, factor 
Xa, and factor XIa inhibitor that prolongs plasma clotting time and inhibits platelet 
aggregation (Kim et al., 2015a).  A serpin from H. longicornis (HLS-2) was 
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characterized to prolong blood coagulation time in an aPTT assay, but interestingly was 
concluded as inhibiting endogenous serpins due to not binding anti-tick rabbit antibodies 
in a western blot (Imamura et al., 2005). These data support the hypothesis that serpins 
play a role in regulating host defense pathways against tick feeding. In this dissertation, 
biological and biochemical analyses were performed to determine if yeast and/or insect 
cell-expressed recombinant AAS4 and AAS8 were inhibitory serpins and if they 
function in tick feeding physiology. 
Materials and Methods 
Expression of recombinant AAS4 & AAS8 in Sf9 insect cells 
The pIB/V5-His expression plasmid and the Spodoptera frugiperda (Sf), cell 
expression system (Invitrogen, Carlsbad, CA, USA) were chosen for recombinant AAS4 
and 8 expression. Recombinant proteins expressed in the Sf9 system have the native 
signal peptide (SP) cleaved; thus it is not required to remove the nucleotide sequence 
encoding the SP from the open reading frame (ORF) to express the mature recombinant 
protein in this system. To construct the expression plasmid, the AAS4 ORF was sub-
cloned into pIB-V5 His expression plasmids using the following primer set: 5’-
ggtaccGCAATGGTCTCCAAGTTGG-3’ and 5’-
ggatccAAGACTGTGCACTTCACCG-3’ and the AAS8 ORF was sub-cloned into pIB-
V5 His expression plasmids using the following primer set: 5’-
ggtaccGTAATGGCGGGTAGCCGT-3’ and 5’- ggatcCGAGGTGGTTCACTTGACC-
3’. Restriction enzyme sites are lowercase and bolded. Restriction sites used for Sf9 
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expression for both AAS4 and 8 were KpnI and BamHI. Sf9 constructs include the 
Kozak consensus sequence [(G/A) NNATGG], and reverse primers for both systems 
exclude the stop codon to allow for translation through the histidine tag. 
AAS4 was amplified from template cDNA of A. americanum females using the 
following 2-step PCR cycling conditions: 5 min at 94°C, 30 sec at 94°C, 51°C for 30 
sec, 72°C for 90 sec for eight cycles, followed by 30 sec at 94°C, 60°C for 30 sec, 72°C 
for 90 sec, for 30 cycles. AAS8 was amplified from template cDNA of A. americanum 
females using the following 2-step PCR cycling conditions: 5 min at 94°C, 30 sec at 
94°C, 57°C for 30 sec, 72°C for 90 sec for eight cycles, followed by 30 sec at 94°C, 
63°C for 30 sec, 72°C for 90 sec for 30 cycles. PCR products were separated on a 2% 
agarose gel with bands of the expected size excised and purified using the StrataPrep 
DNA gel extraction kit (Agilent Technologies, Santa Clara, CA, USA).  Purified DNA 
was ligated into the pGEM-T vector (Promega), using the pGEM-T TA cloning kit as 
per the manufacturer’s instructions. Following ligation, pGEM-T-AAS4 or pGEM-T-
AAS8 plasmids were transformed into Escherichia coli DH5α competent cells (Life 
Technologies) using the routine heat shock method and plated on lysogeny broth 
(Lennox recipe: 1% w/v tryptone, 0.5% w/v yeast extract, 0.5% w/v NaCl, 1.5% agar, 
distilled water to 1L) agar plates prepared with ampicillin at 100µg/mL, with overnight 
incubation at 37°C.  Ten colonies were selected for PCR verification of plasmid 
insertion using the following pGEM-T primers: T7, 5′-
(TAATACGACTCACTATAGGG)-3′ and SP6: 5′-(TATTTAGGTGACACTATAG)-3′.  
PCR-verified insert-positive colonies were used to inoculate overnight cultures in 7mL 
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of Super Optimal Broth (SOB; 2% w/v bacto-tryptone, 0.5% w/v yeast extract, 8.56mM 
NaCl, 2.5mM KCl, distilled water to 1L pH 7.0), with ampicillin (100µg/mL). 
Simultaneously, empty pIB/V5-His vector plasmids were amplified by inoculating SOB 
media with zeocin at 25µg/mL.  
Both pGEM-T-AAS4 and pGEM-T-AAS8 and empty pIB/V5-His plasmids were 
purified from E. coli cells using the Isolate II Plasmid Mini Kit (Bioline, London, UK) 
and digested using 1µl (10 units) each of the appropriate restriction enzymes (New 
England Biolabs, Ipswich, MA, USA) in a 100µL reaction volume to generate AAS4 or 
AAS8-encoding cDNA inserts and pIB/V5-His plasmids that were digested with the 
same enzymes.  Prepared cDNA inserts were ligated into pIB/V5-His plasmids using T4 
DNA ligase (New England Biolabs, Ipswich, MA, USA). The ligation reaction was 
incubated at 16°C overnight and transformed into E. coli DH5α competent cells using 
the routine heat shock method. Ten colonies were selected for PCR verification of 
plasmid insertion using pIB/V5-His OpIE2 primers: 5’-
CGCCACGATCTGGTAAACAC-3’ and 5’-
GACAATACAAACTAAGATTTAGTCAG-3’. PCR-verified insert-positive colonies 
were processed for plasmid purification using routine procedures, as previously 
described. Purified plasmids were sequenced using the OpIE2 and the BigDye 
Terminator Kit to verify proper cloning of AAS4 and AAS8 and to confirm the insert 
was cloned in the pIB/V5-His expression plasmids in-frame with the 6xHistidine tag.  
         Following verification of sequences, the pIB/V5-His-AAS4 and pIB/V5-His-
AAS8 expression plasmids were purified as previously described. Prior to transfection, 
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2mL cultures of Sf9 cells were prepared in each of three wells of a 6-well plate, grown 
overnight at 28ºC. For transfection, 1µg of purified pIB/V5-His-AAS4 and -8 plasmids 
was diluted in 100µl SF900 II serum free media (SFM) (Invitrogen, Carlsbad, CA, USA) 
and incubated at room temperature (RT) for 30min. Simultaneously, 8µl of Cellfectin II 
reagent (Invitrogen, Carlsbad, CA, USA) was incubated with 100µl SF900 II SFM at RT 
for 30min. Cellfectin II reagent and pIB/V5-His-AAS4 and pIB/V5-His-AAS8 reactions 
were combined and after mixing gently the combined reaction was incubated at RT for 
15min. After incubation, all 200µl of the combined reaction was added to Sf9 cells 
carefully in a drop-wise manner. Following transfection Sf9 insect cells were maintained 
in the 6-well plate in SF900 II SFM and incubated at 28°C. To confirm expression, one 
well was analyzed at each of 48h, 72h, and 96h. Collected culture samples were 
centrifuged at 1,500xg for 10min to separate media from cells. Media was concentrated 
by adding 4 volumes of ice-cold acetone, vortexing briefly, and incubating overnight at -
20ºC. The following day, precipitated recombinant (r) protein was harvested by 
centrifugation at 10,000xg for 30min, acetone was decanted, and pelleted protein was 
dried completely at room temperature. After drying, protein was resuspended in 50µl of 
PBS. Both the concentrated media and cell lysates were subjected to western blot 
analysis for recombinant (r) proteins rAAS4 and rAAS8 expression, detected using 
horseradish peroxidase (HRP)-conjugated antibodies to the carboxy-terminus histidine 
tag (Life Technologies). After confirming expression, transfected cells were cultured to 
confluence in a T75 flask.  Once confluent, positively transfected cells were selected by 
supplementing SF900 II SFM media with blasticidin at 50µg/mL. Selected cells were 
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cultured to confluence in medium containing blasticidin at 10µg/mL. At confluence, 
media was collected and cells sub-cultured to new T75 flasks every two days. Media was 
concentrated using Jumbosep columns with 10K membrane inserts (Pall Corporation, 
Port Washington, NY, USA). Concentrated protein was dialyzed against PBS in the 
same column. Dialyzed protein was diluted with 2x affinity purification binding buffer 
(100mM Tris-HCl/500mM NaCl/5mM Imidazole, pH 7.4) to a 1x concentration and 
filtered through a 0.2µM filter in preparation for purification. 
 
Expression of recombinant AAS4 & AAS8 in X-33 yeast cells 
Cloning of the AAS4 and AAS8 ORFs using the KpnI and SacII restriction sites 
for both AAS4 and AAS8into pPicZα-A expression plasmids and transformation of 
Pichia pastoris X-33 cells (Cereghino and Cregg, 2000) with pPicZα-A-AAS4 and 
pPicZα-A-AAS8 was previously performed in the lab by Tae Kim (unpublished), as 
specified by the manufacturer (Invitrogen, Carlsbad, CA, USA). After confirming 
successful expression and determining optimal culture time, large-scale expression was 
performed in this dissertation. First, a primary seed was grown by inoculating 10mL of 
Buffered Glycerol Complex Medium (BMGY) from successfully expressing colonies 
and incubated overnight at 28ºC in an incubator/shaker shaking at 250rpm. The 
following day a secondary seed was inoculated by combining the 10mL culture with 
250mL of BMGY and grown a second night under the same conditions. On the third 
day, cells from the overnight culture were separated from media by centrifugation and 
resuspended to Buffered Methanol Complex Medium (BMMY) as previously described. 
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Cultures in BMMY were incubated for five days as determined optimal by pilot 
expression. On the fifth day, cells were separated from media by centrifugation and 
discarded. Media was concentrated by ammonium sulfate precipitation to an 80% 
saturation overnight at 4ºC (Jiang et al., 2004). Concentrated protein was pelleted by 
centrifugation and resuspended in PBS. The resuspension was dialyzed against PBS, 
diluted with 2x affinity purification binding buffer (100mM Tris-HCl/500mM 
NaCl/5mM Imidazole, pH 7.4) to a 1x concentration and filtered through a 0.2µM filter 
in preparation for purification. 
 
Affinity purification of rAAS4 and 8 
Expressed rAAS8 from both systems, and rAAS4 from X-33 were affinity-
purified using the affinity chromatography His Trap columns (GE Healthcare Life 
Sciences) under native conditions (Hoffman and Roeder, 1991; Schmitt et al., 1993). A 
preliminary pilot expression was performed to determine optimal purification conditions. 
First, the purification column was washed with 5mL deionized, autoclaved water to flush 
out storage solution. The column was then charged by binding 5mL 100mM NiCl2 to the 
chromatography matrix inside the column followed by 25mL 1X binding buffer (20mM 
Tris, 1M NaCl, 10mM imidazole, pH 7.4) to optimize column conditions for protein 
binding. Next, rAAS4 and rAAS8 diluted in an equal volume of 1X binding buffer were 
applied to the column. The column was then washed with a series of buffers with 
increasing concentrations of imidazole: 5mM, 25mM, 50mM, 100mM, 300mM, and 
500mM. All volumes passing out of the column following application (buffer and any 
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unbound protein) were designated as ‘eluates.’ Eluates following protein and wash 
buffer applications were subjected to western blot analysis with rAAS4 and 8 elutions 
detected using antibodies to the histidine-tag. After determining optimal elution 
conditions, large scale expression was performed until all rAAS4 and 8 was purified. 
Eluted rAAS4 and 8 were concentrated on a Microsep column (Pall Corporation, Port 
Washington, NY, USA) and dialyzed on the same column to 20mM Tris-HCl/150mM 
NaCl, pH 7.4. Dialyzed protein was quantified using the BCA kit (Thermo Fisher 
Scientific, Waltham, MA, USA) (Hill and Straka, 1988) in which light emissions from 
samples of known BSA concentrations are used to plot a regression line and readings 
from samples of unknown concentration are used in the regression equation to calculate 
the unknown concentration values. The microplate protocol for this kit was used and 
samples were read on the Synergy H1 plate reader (BioTek Instruments Inc., Winooski, 
VT, USA). A pure rAAS4 product was verified by SDS-PAGE with silver staining, 
which has a high sensitivity to non-specifically detect proteins (Merril et al., 1984). 
Using this staining method, any contaminating proteins will be detected. Western blot 
analysis using antibodies to the histidine tag (Pogge von Strandmann et al., 1995) was 
performed to confirm observed band is the expected recombinant protein. 
 
Deglycosylation assays 
Sequence analysis of AAS4 and AAS8, using the NetNGlyc 1.0 server, showed 
there are two N-glycosylation sites predicted for this protein (Mulenga et al., 2007). To 
determine if rAAS4 and rAAS8 are N-glycosylated in the recombinant Sf9 and X-33 
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expression systems, deglycosylation treatments were conducted using PNGase F or 
deglycosylation enzyme mix.  Peptide N-glycosidase F (PNGase F) was first reported 
from Flavobacterium meningosepticum as an enzyme that cleaves oligosaccharide 
chains that are asparagine (N)-linked (Plummer et al., 1984). The deglycosylation mix 
contains PNGase F and four further enzymes: O-Glycosidase, Neuraminidase, β1-4 
Galactosidase, and β-N-acetylglucosaminidase. The activity of these four enzymes 
results in the removal of saccharides linked to either serine or threonine amino acids.   
For the deglycosylation mix assay, ~5µg of rAAS4 and 8 in 9µl aliquots were 
combined with 1µl of 10X Glycoprotein Deglycosylation Buffer in a 0.2mL Eppendorf 
tube and incubated at 100ºC for 10mins. The reaction was then cooled on ice, followed 
by the addition of 2.5µl of 10X G7 reaction buffer, 2.5µl of 10%NP40, 9µl of deionized, 
autoclaved water, and 1µl of deglycosylation enzyme mix or water for the control 
reaction. Reactions were mixed gently and centrifuged in a microfuge to collect liquids 
to the bottom of the tube. Reactions were incubated for four hours at 37ºC in the 
Thermal Cycler System 9700 (Applied Biosystems, Foster City, CA). For the PNGase F 
assay, similar concentrations of rAAS4 and rAAS8 as above were mixed with 1µl of 
Glycoprotein Denaturing Buffer in a 0.2mL Eppendorf tube and incubated at 100ºC for 
10mins. The reaction was then cooled on ice, followed by the addition of 2µl of 10X G7 
reaction buffer, 2µl of 10% NP40, 5µl of deionized, autoclaved water, and 1µl of 
PNGase F enzyme (New England Biolabs, Ipswich, MA, USA) or water for the control 
reaction. Reactions were mixed gently and centrifuged in a microfuge to collect liquids 
to the bottom of the tube. Reactions were incubated for one hour at 37ºC in the Thermal 
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Cycler System 9700 (Applied Biosystems, Foster City, CA). Results were analyzed by 
SDS-PAGE and western blot analysis using antibodies to the histidine tag.  
 
Screening against tick-exposed rabbit antibody 
 The criteria for selecting protein antigens for use as an anti-tick vaccine are that 
the protein be secreted into the vertebrate host and that it be immunogenic. To determine 
if AAS4 and AAS8 were secreted and immunogenic, western blotting analysis was 
performed using rabbit antibodies to tick saliva proteins from A. americanum that were 
fed for 48h. These antibodies were generated in New Zealand white rabbits that were 
repeatedly infested for up to 48h (Chalaire et al., 2011). Ticks were allowed to attach for 
48h before being manually detached, and replaced with unfed ticks in a process that was 
repeated until an antibody response in rabbits was confirmed. Affinity-purified rAAS4 
and rAAS8 were electrophoresed on a 10% sodium-dodecyl polyacrylamide gel (SDS-
PAGE) and electroblotted onto a polyvinylidene difluoride (PVDF) membrane 
(Millipore, Billerica, MA, USA). After blocking the membrane with 0.05% skim milk 
diluted in 1X phosphate-buffered saline (PBS)/0.05% TWEEN detergent, the membrane 
was cut with a razor blade to separate it into individual lanes containing recombinant 
protein. Lanes were incubated in rabbit antibody to tick saliva protein or pre-immune 
sera at various dilutions: 1:25, 1:50, or 1:100 for rAAS8 and 1:50, 1:250, and 1:1000 for 
rAAS4. Membrane strips were incubated for 1h at room temperature. Subsequently 
membranes were washed in PBS-tween (three times at 5 min each) to remove unbound 
antibodies. Washed membranes were incubated in horseradish peroxidase (HRP) 
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conjugated goat anti-rabbit IgG (Millipore, Billerica, MA, USA) diluted in blocking 
buffer for 1h at RT. After one hour of secondary antibody binding, membranes were 
washed of any excess antibody and then exposed to 1X 3,3'-diaminobenzidine 
tetrahydrochloride (DAB) and Stable Peroxide Substrate Buffer (Kruger 1994) (DAB 
Substrate Kit) (Thermo Fisher Scientific, Waltham, MA, USA) which reacts with HRP 
to create a brownish stain on the membrane, or developed using the Amersham ECL 
Western Blotting Detection Kit (GE Healthcare Life Sciences, Pittsburgh, PA, USA).  
 
Heparin binding 
 Comparative secondary structure modeling predicted that AAS8 had basic 
patches capable of binding heparin (Mulenga et al., 2007). Therefore, to determine if 
putative heparin biding sites on AAS8 were functional, a heparin-binding assay was 
performed. The assay was performed according to the heparin column manufacturer. For 
the assay, ~15µg of AAS8 was diluted in 5mL of binding buffer (10mM sodium 
phosphate buffer, pH 7.0) and filtered through a 0.45µM filter. The sample was then 
bound to a HiTrap Heparin HP 1mL affinity-chromatography column (GE Healthcare, 
Bio-Sciences, Pittsburgh, PA, USA) that was pre-washed with 10mL of binding buffer, 
and sample eluates were collected. The column was then washed with 10mL of binding 
buffer and eluates were collected. To elute any AAS8 bound to the column, 10mL of 
elution buffer (10mM sodium phosphate, 1.5M NaCl, pH 7.0) was passed through the 
column and the eluent was collected. Eluates and the eluent were concentrated on a 
Microsep column (Pall Corporation, Port Washington, NY, USA) and buffer exchanged 
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to PBS on the same column. Samples were analyzed by SDS-PAGE and western blot 
analysis using antibodies to the histidine tag.   
 
Inhibitor function profiling 
Some serpins have been described that serve non-inhibitory roles, such as 
chaperone or transport functions (Law et al., 2006) and some serpins inhibit proteases 
not of the serine catalytic type. Therefore, the purpose of this assay was to assess 
whether or not AAS4 and AAS8 function as inhibitors of serine proteases. Purified 
rAAS4 and AAS8 were screened against a panel of proteases as listed in Table 6. This 
list comprises 16 serine proteases and one cysteine protease with known functions in 
blood clotting, platelet aggregation, and/or other vertebrate defense pathways. For this 
assay, 1M (5µg) rAAS4 or rAAS8 in 20mM Tris/150mM NaCl, pH7.4 was pre-
incubated with each protease, with final protease concentrations as listed in Table 6. The 
reaction buffer (20mM Tris/150mM NaCl/0.1% Bovine Serum Albumin (BSA), pH7.4) 
was added to the reaction up to a volume of 80µl. BSA is added to the buffer to stabilize 
the proteases. After vortexing briefly, reactions were incubated for 15 min at 37°C and 
then aliquoted into in a 96-well plate. Chromogenic substrate at concentrations indicated 
in Table 6, were added to the reaction to 200mM final substrate concentration. The 
appropriate substrate was added to all reaction wells simultaneously using a multi-
channel pipette. Reactions were immediately read using the Synergy H1 plate reader 
(BioTek Instruments Inc., Winooski, VT, USA) at A405nm every 30 seconds for 30 
minutes at 37°C. Raw data was exported and analyzed in Prism 6 software (GraphPad  
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Table 6: List of vertebrate proteases against which AAS were screened 
Protease 
Final 
Concentration 
Activity Protease 
Final 
Concentration 
Activity 
Trypsin (Bovine Pancreas) 21.01 nM No Thrombin (Bovine Plasma) 2.71 nM No 
α-Chymotrypsin (Bovine 
Pancreas) 
2 nM No Factor VIIa  No 
Plasmin (Human Plasma) 11.63 nM No Factor IXa (Bovine) 31.44 nM No 
Elastase (Porcine Pancreas) 6.18 nM No Factor Xa 4.65 nM No 
Chymase (Human Recombinant) 4.50 nM No Factor XIa (Human) 3.69 nM No 
Proteinase 3 (Human Neutrophil) 779.31 nM Yes Factor XIIa (Human, α-) 2.03 nM No 
Cathepsin G (Human) 216.67 nM Yes Urokinase (Human 
Recombinant) 
9.26 nM No 
Papain 2.14 μM No Tissue Plasminogen Activator 
(Human) 
4.73 nM No 
Kallikrein (Porcine Pancreas) 19.05 nM No 
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Software, La Jolla, CA, USA). Residual protease activity was calculated using the 
Michaelis-Menten kinetics equation: Vmax (Vh)/Vmax (V0) versus inhibitor 100 − Vmax 
(Vi)/Vmax (V0) × 100 where Vmax (Vi) = protease activity in  
The effect of rAAS4 on platelet aggregation time was assessed using the purified 
platelets method. Fresh rabbit blood was collected into 8.5 mL vacutainers containing 
1.5 mL anti-coagulant acid citrate dextrose solution (Becton Dickinson, Franklin Lakes, 
NJ, USA) and centrifuged at 200xg for 20 min at 18°C. The platelet-rich plasma top 
layer was decanted into 15mL conical tubes and centrifuged at 800xg for 20 min at 
18°C. Supernatant was discarded and pellet was washed in Tyrode buffer (137 mM 
NaCl, 2.7 mM KCl, 12 mM NaHCO3, 0.42 mM Na2HPO4, 1 mM MgCl2, 0.1% glucose, 
0.25% BSA). The pellet, containing platelets, was resuspended in Tyrode buffer to an 
OD650 of 0.05. In 50µl reactions, rAAS4 alone, rAAS4 with cathepsin G, or cathepsin 
G alone were incubated at 37°C for 15 min followed by the addition of platelets pre-
warmed at 37°C for 5 min. Clotting time was measured on the Synergy H1 plate reader 
(BioTek Instruments Inc., Winooski, VT, USA) at OD650 for 15 mins at 37°C. Several 
concentrations of rAAS4 were assayed: 2µM, 1µM, 0.5µM, and 0.25µM.  The platelet 
aggregation agonist, cathepsin G, was used at a concentration of 0.6µM. Readings of 
optical density (O.D.) were fitted to the one-phase decay equation in PRISM (GraphPad) 
to determine the O.D. plateau. The percent reduction in platelet aggregation was 
calculated using the following formula: Y = 100 − (ΔPn)/ΔPC) * 100, where Y = % is the 
reduction in platelet aggregation, ΔPn and ΔPC = a respective rAAS-treated and positive 
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control plateau O.D. subtracted from O.D. of the blank plateau. Data are presented as 
mean ± S.E.M. of duplicated platelet aggregation assays.  
  
Effects on blood clotting 
The effect of rAAS4 and rAAS8 on blood coagulation time was assessed using 
four assays: recalcification time assay (RCT), which measures effects on blood clotting 
factors in their entirety, prothrombin time (PT), which measures effects on clotting 
factors important to the extrinsic blood clotting activation pathway, activated partial 
thromboplastin time (aPTT), which measures effects on factors in the intrinsic blood 
clotting activation pathway, and thrombin time (TT), which measures effects on the 
common blood clotting activation pathway as previously described (Mulenga et. al., 
2013a, 2013b).    
         In the RCT assay, the reaction volume was adjusted to 200μL with Tris-HCl 
reaction buffer (20mM Tris-HCl, 150mM NaCl, pH 7.4) and mixed with 50μL universal 
human reference plasma (Thermo Fisher Scientific, Waltham, MA, USA) pre-incubated 
for 15 minutes at 37°C with or without 1 µM rAAS4 or rAAS8 in a 96-well microplate 
prior to the addition of 10μL of 150mM calcium chloride (pre-warmed) to induce 
clotting. RCT was determined using the Synergy H1 plate reader (BioTek Instruments 
Inc., Winooski, VT, USA) at A405nm every 20 seconds for 20 minutes at 37°C. 
 The PT, aPTT, and TT assays were performed according to instructions by the 
Pacific Hemostasis manufacturer of the clotting activation reagent with modifications 
(Thermo Fisher Scientific, Waltham, PA).  For the PT assay, the reaction volume was 
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adjusted to 200μL with Tris-HCl reaction buffer, and 100μL thromboplastin (Pacific-
Hemostasis-Prothrombin Time Reagent; Thermo Fisher Scientific, Waltham, MA, USA) 
was pre-incubated with or without 1 µM rAAS4 or rAAS8 at 37°C for 15 min before 
adding 50μL universal human reference plasma. For the aPTT assay, the reaction 
volume was adjusted to 200μL with Tris-HCl reaction buffer and 50μL universal human 
reference plasma was pre-incubated with 1 µM rAAS4 or rAAS8 at 37°C for 15 min 
before adding 50μL aPTT reagent (Thermo Fisher Scientific, Waltham, MA, USA) 
followed by the addition of 50μL of 25mM calcium chloride to induce clotting. For the 
TT assay, the reaction volume was adjusted to 100μL with Tris-HCl reaction buffer and 
25μL of thrombin time reagent (Thermo Fisher Scientific, Waltham, MA, USA) was 
pre-incubated with or without 1 µM rAAS4 or rAAS8 at 37°C for 15 min. Following 
incubation, 50μL universal human reference plasma was added to the reaction. PT, 
aPTT, and TT assays for rAAS8 were monitored and recorded using the KC1 Delta 
semi-automated coagulation analyzer (Trinity Biotech, Parsippany, NJ). PT, aPTT, and 
TT assays for AAS4 were monitored and recorded using the Synergy H1 plate reader 
(BioTek Instruments Inc., Winooski, VT, USA) where an increase in OD is directly 
proportional to an increase in clotting.  
 
Results 
Recombinant (r) AAS4 and rAAS8 are ~50kDa glycoproteins 
To test the hypothesis that AAS4 and AAS8 are functional serpins involved in 
host immune system counter-defense at the tick feeding site, the recombinant (r) proteins 
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were expressed for functional assays. Figure 7 summarizes the cloning of AAS4 and 
AAS8 ORFs into pIB-V5-His, the expression of recombinant (r) AAS8 in Sf9 cells, and 
the expression of rAAS4 and rAAS8 in X-33 cells. While both AAS4 and AAS8 
expression constructs were successfully ligated into the insect cell expression vector 
pIB-V5 (Figure 7a and b) only rAAS8 was successfully expressed in the insect S. 
frugiperda Sf9 eukaryotic expression system (Figure 7c), while rAAS4 could not be 
expressed in the insect cell system. Prior to this dissertation, both rAAS4 and rAAS8 
were successfully cloned and expressed in yeast Pichia pastoris X-33 cells. In this  
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Figure 7. Cloning and expression of rAAS4 and rAAS8. Panel A and B 
show PCR verification of AAS4 and AAS8 construct successful ligation into 
pIB-V5 expression vector for insect cell expression. Panel C shows 
chemiluminescence detection of insect cell Sf9-expressed rAAS8 using anti-
His tag antibodies. Panel D shows chemiluminescence detection of yeast cell 
X-33-expressed rAAS4 and rAAS8 using anti-His tag antibodies.  
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dissertation, experiments were performed with X-33-expressed rAAS4 (since Sf9 
expression failed), and both X-33- and Sf9-expressed rAAS8 (Figure 7c and d). Both 
rAAS4 and rAAS8 were successfully affinity-purified as revealed by silver and 
Coomassie brilliant blue staining and western blot analysis using antibody to the 
histidine tag (Figure 8a and b; Figure 9a and b). Mature AAS4 (GenBank ABS87356.1) 
and AAS8 (GenBank ABS87360.1) are 381 and 375 amino acid residues long, 
respectively, with a calculated molecular weight (Mw) of 41.422 and 41.362 kDa,  
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Figure 8. Affinity-purification of rAAS8. Panel A shows a silver stained gel of 
affinity-purified rAAS8. The figure shows that rAAS8 elutes from the affinity-
purification as a single band at a molecular weight (Mw) of ~50 kDa, which is much 
higher that the calculated Mw for rAAS8 of 41.362 kDa. Panel B shows western blot 
analysis of rAAS8 affinity-purification wash and elution eluates using anti-His tag 
antibody. Lanes 7 and 10 are marker lanes. Lane 1 is pre-purified protein. Lane 2 is 
column eluate after applying rAAS8. Lanes 3-6 are 5, 25, 50, and 100 mM imidazole 
washes. Lanes 8, 9, and 11-13 are the five serial fractionated eluates from the 300 
mM imidazole wash. Western blot detection is very sensitive and detected elution of 
rAAS8 not only in the 3
rd
, 4
th
, and 5
th
 fractions of the 300 mM imidazole washes, but 
also in the 1
st
 and 2
nd
 fractions, and in the 100 mM imidazole wash.  
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respectively (Mulenga et al., 2007). In the pIB-V5 expression system ~3 kDa is added 
due to the polyhistidine tag, and in the pPicZα-A expression system ~2.5 kDa is added  
due to the polyhistidine tag. This increases the predicted Mw to 43.9 kDa for yeast-
expressed rAAS4, and 43.862 and 44.362 kDA for yeast-expressed and insect cell-
expressed rAAS8, respectively. In Figures 7 and 8, both rAAS4 and rAAS8 migrated at 
around 50 kDa (Lanes 1, 6, 8, 9, 11, and 12 for AAS8; Lanes 2, 5, and 8), which is  
higher than the calculated Mw, even with the tag. For rAAS4, a second band was also  
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Figure 9. Affinity-purification of rAAS4. Panel A shows western blot analysis of 
rAAS4 affinity-purification wash and elution eluates using anti-His tag antibody. 
Lanes 1 is a marker lane. Lane 2 is pre-purified protein. Lane 3 is column eluate after 
applying rAAS4. Lanes 3-5 are 5, 50, and 100 mM imidazole washes. Lanes 6-10 are 
the five serial fractionated eluates from the 300 mM imidazole wash. Note that 
rAAS4 elutes in the 100 mM imidazole wash and in the 3
rd
 fraction of the 300 mM 
wash. Panel B shows a silver stained gel of affinity-purified rAAS4. The figure 
shows that rAAS4 elutes from the affinity-purification column as two bands, one at 
the calculated molecular weight (Mw) for rAAS4 (~41.422 kDa) and another band at 
~50kDa.  
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consistently observed below the 50 kDa band, as shown in Figure 9b. Previous 
NetNGlyc analysis revealed three and two putative N-linked glycosylation sites in AAS4 
and AAS8, respectively (Mulenga et. a., 2007). Additionally, the affinity-purified 
recombinant proteins migrated at higher than expected Mws. To confirm in silico 
glycosylation predictions and to determine if the observed migration at ~50kDa for the 
recombinant proteins was due to N- or O-linked glycosylation post-translational  
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Figure 10. Deglycosylation of rAAS4 and rAAS8. Panel A shows the 
deglycosylation of rAAS8 and Panel B shows the deglycosylation of rAAS4. 
Reactions were with PNGase F enzyme (E) or control without enzyme (C) and 
deglycosylation mix with enzyme (E) or control without enzyme (C). The figures 
shows removal of N-linked sugar moeities from rAAS4 and 8 by PNGase F as seen 
by the downward molecular weight (Mw) shift, and no further downward shift in Mw 
with N- and O-linked sugar moeity removal using deglycosylation mix. These results 
indicate that there is no O-linked glycosylation of rAAS4 or rAAS8. The more 
pronounced downward shift in Mw for rAAS4 after PNGase F treatment supports the 
prediction of three N-linked glycosylation sites for this protein over the two predicted 
N-linked glycosylation sites for AAS8. The moderate downward shift in Mw for 
rAAS8 indicates an incomplete deglycosylation or that other post-translational 
modifications are present. 
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modification, affinity-purified rAAS4 and rAAS8 were subjected to deglycosylation 
assays. As predicted by NetNGlyc 1.0, Figure 10a and b shows that both rAAS4 and 
rAAS8 decrease in molecular weight (Mw) when treated with PNGase F, which removes 
N-linked sugar moieties, as compared to the control reaction with no PNGase F. The 
decrease in Mw for rAAS8 was a very moderate, while for rAAS4 the Mw shift was 
very dramatic (Figure 10a and b). Similarly, both rAAS4 and rAAS8 decrease in Mw 
when treated with deglycosylation mix, which removes both N- and O-linked sugar 
moieties. However, there is no additional downward Mw shift when treated with 
deglycosylation enzyme mix as compared to the PNGase F treatment showing that 
rAAS4 and rAAS8 do not have O-linked glycans (Figure 10a and b). These data confirm 
the in silico predictions of N-linked glycosylation sites for AAS4 and AAS8 (Mulenga et 
al., 2007). These data also confirm that for rAAS4, the migration at 50 kDa is due to N-
linked glycosylatinon, while for rAAS8 N-linked glycosylation only partially explains 
the higher than expected migration of this recombinant protein. 
 
Both AAS4 and AAS8 are immunogenic and injected into the host during tick feeding  
 To determine if AAS4 and AAS8 are immunogenic proteins and whether or not 
native AAS4 and AAS8 are injected into the host during tick feeding, rAAS4 and rAAS8  
were subjected to western blot analysis using rabbit antibodies to tick saliva proteins as 
summarized in Figure 11a and b. Both rAAS4 and rAAS8 specifically bound antibodies 
from rabbits repeatedly parasitized by A. americanum ticks for up to 48h, at 1:1000 and 
1:100 dilutions, respectively. However, for rAAS4, it was observed that rabbit antibodies  
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Figure 11. Binding to rAAS4 and rAAS8 of rabbit antibody to tick saliva proteins.  Panel A shows binding to 
rAAS8 of antibody from tick-exposed rabbits (TE) at a dilution of 1:100, while antibody from pre-immune rabbits 
(PI) at the same dilution did not bind rAAS8. The marker is indicated (M). Panel B shows binding to rAAS4 of 
antibody from tick-exposed rabbits (TE) at a dilution of 1:1000, while antibody from pre-immune rabbits (PI) at the 
same dilution did not bind rAAS4. TE antibody bound to a band corresponding in molecular weight (Mw) to the non-
glycosylated form of the recombinant protein, therefore the assay was repeated with both glycosylated (G) and de-
glycosylated (D) rAAS4, Panel C. Using his-tag antibody the bands corresponding to glycosylated and de-
glycosylated rAAS4 can be compared to bands where TE antibody bound to rAAS4. TE antibody bound only to a 
band at the same Mw as de-glycosylated rAAS4 and not to a band at the same Mw as glycosylated rAAS4, indicating 
ticks secrete only non-glycosylated AAS4 into the feeding site. 
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to tick saliva proteins bound the lower Mw protein band that is similar in size to 
deglycosylated rAAS4 shown in Figure 10b. To verify these data, both glycosylated and 
de-glycosylated rAAS4 were subjected to western blot analysis using antibodies the 
histidine tag and antibodies to tick saliva proteins. As shown in Figure 11c, the antibody 
to the histidine tag bound the diffuse protein band (50-75kDa) in glycosylated (G) lane  
and a single protein (under 50 kDa) in the de-glycosylated rAAS4 lane (D). 
Interestingly, rabbit antibodies to tick saliva proteins did not bind the high Mw diffuse 
protein band, rather it bound a single protein band in glycosylated (G) similar in Mw to 
the de-glycosylated form (D).  
 
rAAS4 and AAS8 inhibit proteases in inflammation pathways  
 To test the hypothesis that AAS4 and AAS8 function in counter-defense against 
the host immune system, affinity-purified rAAS4 and rAAS8 were subjected to inhibitor 
function profiling against the proteases listed in Table 6. Proteases were chosen based on 
their known roles in host defense pathways including blood coagulation and platelet 
aggregation, inflammation, and other immune system pathways.  The inhibitory 
activities of rAAS4 and rAAS8 at 1 M final concentration were assessed against 
proteases at concentrations indicated in Table 6. For rAAS8, inhibitory activity was not 
detected for 15 of 17 proteases however, inhibitory activity was detected for two 
inflammatory proteases, proteinase 3 and cathepsin G, as shown in Figure 12.   
Proteinase 3 was moderately inhibited (41.13 ± 7.5%) by rAAS8, as was cathepsin G by 
14 ± 9.33%. No inhibitory activity was detected for 14 of 17 proteases by rAAS4, 
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however, inhibitory activity was detected for three proteases: papain, chymase, and 
cathepsin G as shown in Figure 13. Inhibition of papain was most pronounced at 67 ± 
1.08%, followed by cathepsin G by 56.30 ± 4.48%, while inhibition of chymase was the 
lowest at 31.54 ± 3.65%. Both chymase and cathepsin G are involved in the vertebrate 
inflammatory response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 12. Inhibition of proteinase 3 and cathepsin G by rAAS8. The 
figure shows that rAAS8 inhibits proteinase 3 at 41.13±7.5%, and human 
cathepsin G at 14±9.33%. Each reaction was 100 µl in volume with 1µM 
final concentration of rAAS8, proteinase 3 at a final concentration of 779.31 
nM, and cathepsin G at a final concentration of 216.67 nM.  Assays were 
performed in triplicate and data are shown as mean values from triplicate 
assays. 
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Recombinant AAS8 binds to heparin 
Heparin is a polysaccharide that can bind to serpins and change their inhibitory 
properties (Bjork and Lindahl, 1982; Radulović et al., in preparation). Data in this 
dissertation indicate AAS8 is among the proteins injected by ticks into the feeding site  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Inhibition of papain, cathepsin G, and chymase by 
rAAS4. The figure shows that rAAS4 inhibits papain at 
67±1.08%, human cathepsin G at 56.30±4.48%, and human 
chymase at 31.54±3.65%. Each reaction was 100 µl in volume 
with 1 µM final concentration of rAAS4 with papain at a final 
concentration of 2.14 µM, cathepsin G at a final concentration of 
216.67 nM, and chymase at a final concentration of 4.50 nM.  
Assays were performed in triplicate and data are shown as mean 
values from triplicate assays. 
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where they would be exposed to blood and blood components such as heparin. Since 
exposure to heparin may affect the function of AAS8 and since previous predictions in 
our lab indicated that AAS8 may have heparin binding sites (unpulished), the ability of 
rAAS8 to bind heparin was tested. As shown in Figure 14, rAAS8 was detectable in the 
elution buffer that passed through the heparin column, indicating that the protein bound 
heparin. As expected, rAAS8 was not detectable in wash buffer that passed through the 
column nor in the buffer that passed through the column when rAAS8 was applied. This 
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Figure 14. Binding of rAAS8 to heparin. 
The figure shows chemiluminescence 
detection of rAAS8 in protein application, 
wash, and elution eluates from a heparin 
column. Lane 1 is the eluent, lane 2 is the 
wash buffer after rAAS8 binding, and lane 3 
is eluate from binding rAAS8 to the heparin 
column. Detection of rAAS8 occurred only in 
elution eluate showing that all rAAS8 applied 
to the column was bound and eluted only 
after application of elution buffer.  
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shows that all rAAS8 that was applied to the column was retained inside the column and 
eluted out of the column only with the application of elution buffer. Interstingly, it has 
been shown that serpin affinity for heparin binding is at least in some cases dependent on 
extent of serpin glycosylation (McCoy et al., 2003) therefore it will be interesting to 
determine if native AAS8 is also glycosylated to the extent of rAAS8. 
 
AAS4 and AAS8 do not affect the blood coagulation cascade, but AAS4 moderately 
inhibits cathepsin G-induced platelet aggregation 
To test the effect of rAAS4 and rAAS8 on anti-hemostasis, four blood 
coagulation assays were performed: Recalcification Time (RCT), Prothrombin Time 
(PT), Thrombin Time (TT), and Activated Partial Thromboplastin Time (aPTT). 
However, there was no effect on blood clotting time (rAAS8) or plasma clotting time 
(rAAS4) when rAAS4 and rAAS8 were added to the reaction as compared to controls. 
Similarly, there was no difference in platelet aggregation between reactions with rAAS8 
and controls. Taken together, these data indicate that rAAS8 may not function in anti-
hemostasis. However, a difference in platelet aggregation time was observed for 
reactions with added rAAS4 as compared to controls. As shown in Figure 15, cathepsin 
G-induced platelet aggregation was reduced by 60.22%. These data suggest that AAS4 
but not AAS8 inhibit cathepsin G strongly enough to affect platelet aggregation. The 
observed inihibition of platelet aggregation by rAAS4 as shown in Figure 15 is 
consistent with inhibitor function profiling for this protein (Figure 13) where rAAS4 
inhibited cathepsin G activity by 56.5%.  
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Discussion 
Post-translational modifications (PTMs) including glycosylation may be critical 
for proper protein functionality. As a result, eukaryotic expression systems such as the S. 
frugiperda Sf9 insect cell and P. pastoris X-33 yeast cell expression systems are the 
preferred choice for recombinant expression of eukaryotic proteins. Indeed, the 
 
Figure 15. Effect of rAAS4 on platelet aggregation. The figure shows that rAAS4 
at 1µM final concentration inhibits cathepsin G-induced platelet aggregation by 
60.22%. In the assay, cathepsin G at a final concentration of 0.7 µM was used to 
induce clotting of purified platelets in a 50 µL reaction, with or without rAAS4. 
Platelet aggregation was measured on a plate reader at an OD of 650nm for 10 min 
at 37ºC and was performed in duplicate. Data are presented as the mean ± S.E.M. of 
duplicated assays. 
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observation of rAAS4 and rAAS8 running at higher than calculated molecular weights 
combined with the Mw shifts in the deglycosylation assay results show that rAAS4 and 
rAAS8 are post-translationally modified in these expression systems. However, 
unexpectedly, after deglycosylation treatment rAAS8 still did not migrate within the 
range of the calculated Mw for this protein. This could be a result of incomplete 
deglycosylation since PNGase F and the deglycosylation mix cannot always remove all 
glycans, or could be an indication that there are other PTMs for this recombinant protein 
such as phosphorylation, acetylation, formylation, ubiquination, or methylation. Most of 
these PTMs would result in molecular weight shifts only in the Dalton range, however, 
ubiquitin for example is an 8.8 kDa protein and attaches to lysine residues (Parker et al., 
2010), of which AAS8 has 13 in its amino acid sequence.  
Also unexpectedly, antibodies to tick saliva proteins did not bind to glycosylated 
rAAS4 protein. Instead, antibodies bound to a band corresponding to the calculated Mw 
for the recombinant protein, and to a band migrating at the same Mw as the 
deglycosylated rAAS4 at to the lower band observed in silver-stained affinity-purified 
rAAS4. This lower band was confirmed by peptide mass fingerprinting to be the 
recombinant AAS4 (unpublished). Taken together, these data suggest that ticks secrete a 
non-glycosylated AAS4 during feeding. If AAS4 functions at the feeding site in a non-
glycosylated form, this would be in contrast to the idea that expression in eukaryotic 
systems is necessary for expressing properly post-translationally modified proteins, and 
it may be worthwhile to repeat AAS4 assays using non-glycosylated protein. This might 
be accomplished by expressing the recombinant protein in a prokaryotic system such as 
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the E. coli BL21 system. Nevertheless, both AAS4 and AAS8 are immunogenic proteins 
that are secreted into the host during feeding as evidenced by the fact that the vertebrate 
host generates specific antibodies against these proteins. Furthermore, liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) data have also suggested the 
presence of both AAS4 and AAS8 in saliva of A. americanum ticks that fed on rabbits 
(Kim et al., in preparation). In proposing that ticks use serpins to evade host defenses, 
the assumption is that these serpins are injected into the host during tick feeding, 
therefore, these data support the hypothesis that these proteins are involved in tick 
feeding physiology. From the perspective of their inclusion in an anti-tick vaccine, the 
fact that rabbit antibodies to tick saliva proteins do not bind to AAS4 glycans is positive 
in that the linear peptide may be sufficient to specifically generate a protective immune 
response.  
In silico annotations are only a first step in determining protein function.  Further 
functional characterization is necessary, particularly for serpins, which may or may not 
function as inhibitors. Additionally, some serpins inhibit proteases of the cysteine 
catalytic type. Therefore, biological and biochemical analyses were used to determine if 
AAS4 and AAS8 are functional inhibitors of serine or cysteine proteases and to 
determine if these proteins function in counter-defense against the vertebrate immune 
system.  
Several studies have characterized tick serpins as having anti-hemostatic function 
(Prevot et al., 2006; Chmelar et al., 2011; Mulenga et al., 2013b; Yu et al., 2013; Ibelli et 
al., 2014; Kim et al., 2015a; Xu et al., 2016). For rAAS4 and rAAS8, however, no delay 
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in blood clotting time was observed in PT, aPTT, TT, and RCT assays as compared to 
controls. While rAAS8 inhibited the serine protease cathepsin G which can initiage 
platelet aggregation, inhibition of cathepsin G was marginal at only 14%. Consequently, 
it is not surprising that rAAS8 did not affect platelet aggregation and is therefore 
unlikely to affect hemostasis by itself. However, in combination with other serpins that 
can affect platelet aggregation, such as rAAS4, hemostasis may effectively be stopped. 
Unfortunately from the perspective of their use in anti-tick vaccines, this would make 
their effect too partial for high vaccine efficacy unless administered as a mixture of 
serpins. 
Recombinant AAS8 also bound to heparin, which is a polysaccharide of the 
glycosaminoglycan (GAG) family found in the secretory granules of mast cells 
(Rabenstein 2002), and if heparin binds to serpins, inhibitory properties of the serpin 
may be enhanced or even negated (Bjork and Lindahl, 1982; Radulović et al., in 
preparation). Heparin, through its activation of antithrombin, it is a critical player in the 
inhibition of the blood clotting cascade (Whisstock et al., 2000). Heparin has been 
shown to bind many serpins (Pratt and Church, 1993; others) and has the potential to 
rearrange the reactive center loop and change the activity of the serpin (Whisstock et al., 
2000). Since heparin is a normal component of blood, it could impact the function of tick 
serpins that are injected into the feeding site. Therefore, future experiments should 
investigate the impact of heparin binding on the ability of AAS8 to inhibit cathepsin G 
and proteinase 3.  
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Analyses in this chapter revealed that both rAAS4 and rAAS8 have inhibitory 
activities against proteases associated the host’s inflammation system. Interestingly, in 
addition to cathepsin G, AAS8 also inhibited the serine proteinase 3. Both cathepsin G 
and proteinase 3 are found in the granules of neutrophils, and are both in the 
chymotrypsin family (Korkmaz et al., 2008). Neutrophils are the first to arrive at sites of 
inflammation, and their proteases function in innate immunity and regulation of 
inflammation as well as tissue remodeling (Korkmaz et al., 2008). In humans, cathepsin 
G and proteinase 3 are have bactericidal properties and cathepsin G alters chemokines, 
cytokines, and cell receptors through proteolysis (Bank and Ansorge, 2001). For 
example, cathepsin G cleaves the receptor PAR4, leading to platelet activation. It is not 
surprising that AAS8 can inhibit both proteinase 3 and cathepsin G since they are very 
similar in sequence and function, having derived from a gene duplication event, and can 
both be inhibited by the same endogenous inhibitor α2-macroglobulin (Korkmaz et al., 
2008).  
In screening rAAS4, protease inhibition was detected not only for cathepsin G 
but also for chymase. Chymase is found in the granules of mast cells that reside in 
vertebrate tissues and are part of the immune arsenal against parasites (Tchougounova et 
al., 2005). Chymase can also activate IL-1β leading to inflammation (Mizutani et al., 
1991) and is a potent chemoattractant for monocytes and neutrophils (Tani et al., 2000). 
Given these roles for chymase, it is easy to see why tick feeding would be facilitated by 
secreting inhibitors of chymase which would block vertebrate inflammation and other 
anti-parasitic defenses. It is not surprising that rAAS4 inhibited cathepsin G and 
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chymase since in humans cathepsin G and chymase are both inhibited by the serpin α-1 
antichymotrypsin (Kalsheker, 1996) More interestingly, I. ricinus salivary protein serpin 
2 (IRS-2) is also an inhibitor of both chymase and cathepsin G (Chmelar et al., 2011). 
This protein inhibits neutrophil inflammation in a mouse model, and like AAS4, effects 
cathepsin G-induced platelet aggregation. Both IRS-2 and AAS4 are found in SG, MG, 
and OV tissues during feeding. The functional similarity of AAS4 and IRS-2 is 
particularly interesting because BLASTP screening of AAS4 against non-redundant tick 
sequences in GenBank shows IRS-2 has a low identity to AAS4 of only 42%, with only 
12/21 amino acids matching in the RCL region. These data demonstrate that amino acid 
identity between serpins may not be predictive of similarity in biological function. From 
the perspective of using in silico analysis for functional predictions, these data underline 
the importance of additional functional characterization to validate those predictions.  
Interestingly, rAAS4 was a cross-class inhibitor, showing inhibition of not only 
serine proteases but also the cysteine proteinase papain. Papain has been shown to 
polarize the innate immune response to the Th2 cytokine profile (Tang et al., 2010; 
Pulendran and Artis, 2012), which is noteworthy because the Th2 response is induced 
against parasites including ticks (Mejri et al., 2001). On the other hand, several studies 
have investigated the Th2 polarization during tick parasitism and have interpreted this as 
a deliberate counter-defense mechanism by ticks (Skallova et al., 2008; Kovář et al., 
2002; Ferreira and Silva, 1999). Nevertheless, the Th2 response is characterized by a 
cytokine profile that promotes production of the anti-parasitic antibody class, IgE 
(Abbas et al., 2011), therefore, it remains unclear why ticks would favor a polarization to 
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a Th2 response, or why ticks would simultaneously secrete promoters and inhibitors of 
this pathway. Future studies should investigate whether the application of AAS4, in vitro 
or in vivo, inhibits polarization to the Th2 profile.  
Results in this chapter suggest that AAS4 and AAS8 are secreted into the host 
and function in counter-defense against the vertebrate immune system. As such they are 
candidates for further analyzing their utility in anti-tick vaccines. However, whether or 
not AAS4 or AAS8 are determined to be effective targets in tick control, the fact that 
they showed inhibition of inflammatory proteases makes them interesting proteins from 
a medical perspective. Of note, dual inhibitors of both cathepsin G and chymase, which 
is the inhibitor profile of AAS4, are considered of therapeutic value in inflammatory 
diseases like chronic obstructive pulmonary disorder (COPD) and asthma (Maryanoff et 
al., 2010). Dozens of human diseases are attributable to aberrant or hyper-active immune 
system function including asthma, allergies, arthritis, Crohn’s diseases, and multiple 
sclerosis (Abbas et al., 2011). Pharmaceuticals that can be used to dampen the immune 
system could result in the reduction of morbidity and mortality for thousands of lives. To 
this end, proteins like AAS4 and AAS8 that show anti-immune function should be 
investigated for their potential use as immune-modulatory drugs. 
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CHAPTER IV  
ANALYSIS OF AMBLYOMMA AMERICANUM SERPIN AAS4, 6, AND 8 SPLICED 
CONSTRUCT IN IMMUNIZATION TRIALS 
 
Introduction 
In preliminary studies, AAS4 (GenBank ABS87356.1), 8 (GenBank 
ABS87360.1) (unpublished), and 6 (GenBank ABS87358.1) (Chalaire et. al., 2011) were 
found in the saliva of fed female ticks, and bound to rabbit antibodies developed against 
tick saliva proteins. These data indicated that AAS4, 6, and 8 are injected into the host 
during tick feeding and are able to induce an immune response.  
Several studies have already shown that immunization with recombinant serpins 
can confer protective anti-tick immunity. In H. longicornis two serpins, HLS1 and 2, 
have been assayed for vaccine efficacy in separate studies. Vaccination of rabbits with 
HLS2 resulted in 43-44.6% mortality in adult and nymphal ticks (Imamura et al., 2005); 
while vaccination of rabbits with HLS1 resulted in 11. 2% and 43.9% mortality in adult 
and nymphal ticks, respectively (Sugino et al., 2003). In a vaccine trial combining R. 
appendiculatus serpins RAS-1 and -2, ticks feeding on vaccinated cattle showed 61.4%, 
28%, and 43% mortality for nymphs, females, and males, respectively (Imamura et al., 
2006). When cattle were immunized with a mixture of R. appendiculatus serpins RAS-3, 
RAS-4, and a putative tick cement protein, Rhipicephalus Immune-dominant Molecule 
36 (RIM36) (Bishop et al., 2002), mortality rates were 39.5% as compared to 12.8% in 
the control (Imamura 2008). In 2010, Jittapalapong et al. immunized rabbits against an 
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R. microplus serpin and found that adult females fed longer but weighed less on average 
than ticks on control rabbits that fed for shorter periods. The female ticks in this study 
that had fed on immunized rabbits also had 67% mortality post-engorgement without 
laying eggs. In another study, the efficacy of vaccination with I. ricinus serpin Iris 
showed 33.6% mortality of nymphs and reduced engorgement for nymphs and adults on 
immunized rabbits (Prevot et al., 2007).  
In A. americanum challenge infestations of rabbits immunized with AAS19, 60% 
of ticks in a second challenge infestation failed to lay eggs, while in both first and 
second challenge infestations ticks feeding on immunized rabbits had smaller average 
engorgement weights (Kim et al., 2015b). The combined results of these studies not only 
demonstrates the importance of serpins in tick feeding but also shows that 
immunizations using recombinant serpins can confer protection against tick feeding and 
serve to reduce overall tick populations. To address whether AAS4, 6, and 8 are suitable 
candidates for inclusion in an anti-tick vaccine, the purpose of this dissertation chapter 
was to assess tick feeding and egg laying performance for ticks fed on rabbits previously 
immunized against a spliced construct of serpin putative immunogenic regions from 
AAS4, 6, and 8. The rationale for immunizing with a construct involving three different 
antigens is, (1) to attempt to synergize the anti-tick effects of the three separate antigens, 
and (2) to allow delivery of equimolar amounts of each of the three antigens. 
Furthermore the use of spliced construct proteins in subunit vaccine design is a 
previously validated strategy (Soria-Guerra et al., 2011). 
  
 104 
Materials and Methods 
Design and synthesis of AAS-4-6-8 spliced construct open reading frame 
To design the AAS4-6-8 spliced construct (AAS4-6-8sc), the corresponding 
amino acid sequences were submitted to the open source Immune Epitope Database and 
Analysis Resource (IEDB) (http://www.iedb.org/) epitope prediction software to predict 
epitopes in these sequences. Amino acid sequences were first screened in SignalP 
version 4.1 (http://www.cbs.dtu.dk/services/SignalP/) to detect the signal peptide 
sequence. The corresponding amino acid sequence was removed before screening for 
immunogenicity. The rationale for this is that the host is exposed only to the mature 
protein.  
Epitope prediction algorithms have been empirically validated as having high 
accuracy (Moutaftsi et. al., 2006). B-cell activation first requires T-cell activation, 
(Abbas et al., 2011) therefore, the inclusion of T-cell antigens is a strategic component to 
vaccine design. Thus AAS4, 6, and 8 sequences were submitted to both T- and B- cell 
epitope prediction algorithms. All B-cell epitopes were included in the spliced construct. 
For T-cell epitope predictions, every possible consecutive nine amino acid string is given 
a score of immunogenicity. T- and B-cell immunogenic regions were mapped onto the 
full AAS4, 6, or 8 amino acid sequence and regions showing low immunogenicity were 
removed, splicing together only the putatively immunogenic regions.  
In order to initiate the response of B cells against an antigen, more than one B-
cell receptor must bind the same epitope. To this end, several studies have shown that 
using tandemly repeating epitopes enhances the titers of neutralizing antibodies in 
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vaccinated animals (Zhang et al., 2002; Shao et al., 2011; Chen et al., 2014). Therefore, 
in this dissertation, one putative immunenic region was selected from each of AAS4, 6, 
and 8 for tandem duplication in the spliced construct. The chosen sequences were ones 
that were predicted to be immunogenic for both B- and T-cells. The coding regions 
corresponding to the spliced immunogenic regions were combined to form a spliced 
ORF construct using the MacVector DNA analysis software. The primary use of 
expressed proteins was for immunization, which does not require proteins in native 
configuration. Therefore, the quick and inexpensive prokaryotic bacterial expression 
method was chosen for recombinant protein expression. The commercial service 
GeneArt (Life Technologies) was used to optimize the spliced construct sequence for 
expression in Escherichia coli, including the restriction enzyme sites KpnI and BamHI. 
The GeneArt service was used to synthesize and clone the synthetic construct into the 
pMA-RQ plasmid. Since the expression plasmid pRSET-A has an N-terminal histidine 
tag, a stop codon was also included in the AAS4-6-8sc ORF construct at the C-terminus 
to stop transcription at the end of the coding sequence and not have transcription 
continue further after the protein coding sequence.  
  
Expression of AAS-4-6-8 spliced construct in bacterium E. coli 
The recombinant AAS-4-6-8 spliced construct (rAAS4-6-8sc) in pMA-RQ from 
GeneArt was transformed into E. coli DH5α competent cells using the routine heat shock 
method as previously described for AAS4 and 8 in Chapter III. Following 
transformation, ten colonies were selected for PCR-verification of successful 
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transformation of pMA-RQ-AAS-4-6-8 into DH5α cells using the pMA-RQ M13 
primers: 5’- TTGTAAAACGACGGCCAG-3’ and 5’- CATGGTCATAGCTGTTTCC-
3’. Following PCR-verification, plasmids were amplified and purified as previously 
described in Chapter III. After purification, plasmids were sequenced and submitted to 
the Gene Technologies Laboratory (GTL), Department of Biology, Texas A&M 
University, for Sanger sequencing to verify the correct spliced construction from 
GeneArt.  
After sequence confirmation, purified pMA-RQ-AAS4-6-8sc plasmids were 
digested with BamHI and KpnI in a 100 µl reaction using 1 µl of each restriction 
enzyme, 10 µl of 10X Digestion Buffer (New England Biolabs), and 1 µl of BSA as 
required for enzyme stability. Simultaneously, empty pRSET-A plasmids were digested 
with the same restriction enzymes. Digestion reactions were incubated overnight at 
37ºC. The following day, digestion reactions were electrophoresed on a 1% agarose gel 
to separate inserts from plasmids. Bands corresponding to the expected size of the insert 
of 1,684 base pairs (bp) or pRSET-A digested plasmids at 2,343 bp, were excised from 
the agarose gel using a razor blade and the insert DNA was purified from the gel slices 
using the Wizard Plus SV Minipreps plasmid purification kit (Promega). Digested 
AAS4-6-8sc inserts were ligated to digested pRSET-A expression plasmids using T4 
DNA Ligase (New England Biolabs) with overnight incubation at 16ºC. The following 
day, pRSET-A-AAS4-6-8sc plasmids were transformed into DH5α competent cells as 
previously described. Insert-positive colonies were identified by PCR using the pRSET-
A T7 primers 5’-AATACGACTCACTATA-3’ and 5’-
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CCACCGCTGAGCAATAACTAG-3’and positive colonies were used to inoculate 
overnight cultures grown in an incubator at 37ºC, with shaking at 225 rpm. The 
following day, plasmids were harvested from cells and purified as previously described. 
Purified plasmids were used in a Big Dye PCR reaction and submitted for sequencing at 
GTL to ensure proper cloning of AAS4-6-8sc in-frame with the start codon and N-
terminal histidine tag. After sequence confirmation, purified pRSET-A-AAS4-6-8sc 
plasmids were transformed into BL21 pLysS De3 expression cells (Promega) using the 
same protocol for DH5α transformation as previously described in Chapter III. Insert-
positive colonies were identified using pRSET-A T7 primers and positive colonies were 
used for pilot expressions.  
For the pilot expression, seed cultures were grown overnight in 3 mL of the 
nutritionally rich bacterial growth media Terrific Broth (12 g/l peptone, 24 g/l yeast 
extract, 9.4 g/l dipotassium phosphate, 2.2 g/l potassium phosphate, Research Products 
International Corp.) with ampicillin at 50 µg/mL, at 37°C in an incubator/shaker. The 
following day, the seed was used to inoculate 20 mL of Terrific Broth and grown at 
37°C with shaking until the culture reached an A600 of 0.4-0.6 as measured on the DU 
640B spectrophotometer (Beckman Coulter). Expression of recombinant AAS4-6-8sc 
was induced by the addition of 1M Isopropyl β -D-1 thiogalactopyranoside (IPTG) to a 
final concentration of 1 µM. Following induction, the culture was grown for 16 h. Cells 
from collected samples were harvested by centrifugation at 10,000 g for 10min. The 
supernatant was discarded and the pellet was resuspended in 1 mL of Phosphate 
Buffered Saline (PBS). A 100 µl aliquot of BugBuster 10X (Millipore) was added to the 
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resuspension and then incubated for 20 min at room temperature (RT) with occasional 
inversion to mix. Following incubation, samples were placed on ice and subjected to five 
3-second rounds of sonication using the Sonic Dismembrator Model 100 (Thermo Fisher 
Scientific).  
After sonication, a 2 µl (2 units) aliquot of DNase I (Thermo Fisher) was added 
to each sample and incubated for 1h at 37ºC. Following incubation, samples were 
centrifuged at 10,000 g for 15 min at 4ºC. Supernatant, representing the soluble fraction, 
was collected and the pellet was resuspended in 100 µl of 1X Denaturing Buffer (100 
mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 8). The resulting pellets were incubated 
for 30 min at RT followed by centrifugation at 10,000 g for 15 min at 4ºC. Supernatant 
was collected representing the insoluble fraction. All samples were analyzed by SDS-
PAGE and western blot analysis using antibody to the histidine tag and chromogenic 
detection as previously described for AAS4 and 8 in Chapter III. 
 
Expression of AAS4-6-8 spliced construct in yeast Pichia pastoris 
The same ORF for AAS4-6-8 spliced construct (AAS4-6-8sc) was redesigned for 
expression in the pPicZα-A and P. pastoris expression system. For unidirectional 
cloning into pPicZα-A, the KpnI (GGTACC) and NotI (GCGGCCGC) restrictions were 
added to the ORF with no stop codon since the histidine tag for pPicZα-A is in the C-
terminus. The expression construct was ordered from GeneArt (Life Technologies) in 
the pMA-RQ plasmid. Plasmids were amplified in E. coli and sequence verified, as 
previously described for pMA-RQ-AAS4-6-8sc. Purified plasmids were digested with 
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KpnI and NotI enzymes (New England Biolabs) and ligated to pPicZα-A (Invitrogen) for 
expression as previously described in Chapter III for AAS4 and 8. Following ligation, 
transformation to DH5α competent cells and sequencing to verify proper cloning was 
performed as previously described. Sequencing-verified pPicZα-A-AAS4-6-8sc 
plasmids were transformed into Pichia pastoris X-33 strain cells as previously 
described, followed by pilot expressions as previously described. 
 
Results and Discussion 
AAS 4, 6, and 8 are predicted as highly immunogenic 
 AAS4, 6, and 8 were predicted to be immunogenic throughout their sequences, as 
shown in Figure 16. Of all three serpins, AAS8 showed the highest number of 
immunogenic regions with a total of 20 predicted B-cell epitopes. AAS4 and 6 had 17 
predicted B-cell epitopes each. Overall sequence immunogenicity for AAS4, 6, and 8 is 
also shown in Figure 16. The highest scoring nine amino acid T-cell epitopes were 
between 0.8124 and 5.3122. Scores for T-cell epitopes were also higher for AAS8 as 
shown in Table 7, with the top T-cell scores being 5.3122, 3.2479, and 2.2892. The 
highest T-cell epitope scores for AAS4 were 4.0434 and 2.3377 and for AAS6 were 
4.06, 2.3377, and 2.0485. Only the highest scoring epitopes were selected for inclusion 
in the sliced construct design. The spliced amino acid construct is shown in Figure 17. 
The ORF size was 1,684 bp and 561aa long with a predicted molecular weight of 64.3 
kDa including the histidine tag. 
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AAS4 
ENDDALLAKAHNHFAVKLLKHLATQNPSSNVFFSPTSIAAAFGMAYAG
ARGSSEAELASVLGHDQVGLTEKSRVLAAYKHLLELMSSPNVTLEVAN
MVLAQNNFQIAESYIQQLHDIFDAELRSVDFANEGPRVAAEVNAWVRG
KTRGKIDGILPEGQPLDMILFIVNAVYFKGAWVTKFDPANTENKPFLN
LGTTEVSKPAMHLTRRFPYTRLGALHAAAVEIPYSGDRFSMVVLLPDS
PTGLAALREGLSLDVLQDVGSKLIFNEVVLRLPKFEMSLRYGLVPAMR
ALGLNVVFGGGANFTGISESTLVRISDAVHKAAVEVNEEGTIAAAVTG
LSFVPISALHAPLPPIQFTVDRPFLYYIRDRSNNRILFIGEVHSL 
AAS6 
ETDDALLAKAHNHFAVKLLKHLAAQNPSSNVFFSPTSIAAAFGMAYTGAGGSSE
AELASVLGHTEVGLTERPRVLAAYKQLLELTSSPNVTLELANLVLAQNNFEVAESY
KQQLRDVFDAELRSVDFANEGSRVAADVNAWVRGKTRGKITSILPEGQSLDVIL
FILNAVYFKGTWLTQFDPSQTKDKPFLNQGTTEVSKPAMNLRRRFPYTHLDALH
AGAVEIPYSGDRFSMVVLLPDSPTGLATLRDGLSLAVLEDIDSKLSFREVVLRLPKF
DMSLRYSLVPAMRALGLNVVFGGGANFSAISESTQIYISDAVHKASVEVNEEGT
VATAVTGISLALSALHTPPPPIQFIVDRPFLYYIRDRSNNRILFIGEVQSL 
AAS8 
QEEQKVANANNEFGFRLLQKIPASSEVNVFFSPYSVSTALAMAYAGARGETQQE
LYDSLAYSSAGLAPDHVPNAHAQHTQALKSPSSSTLLVANTAVVQEGYNVLRVY
LQTLNQSFSAEVSTTNLADEQSLRSINEWVKHHTDGKIERLLSEPLSSDARFVLLN
AIYFKGLWNTPFHSASTFKASFFNAGTERVEVDMMHGQITAGYARDDETNSDV
VDLPYAGLDYSMTIVRPRDRTGADALRQVLTRQVFRRFLSELSETVVNVALPKFKI
EGEYKLRRPLSLLGVSKAFNKDEADFSGINGSRDLFVHDVVHKAVVEVNEEGSQ
AAAVTGVIIYTQSAFVGTPFVVNHPFLFFIRNRQTGDVLFAGQVNHL 
  
Figure 16. Predicted T- and B-cell immunogenic regions for AAS4, 6, and 8. The figure shows highlighted 
regions in the amino acid sequences of AAS4, 6, and 8 that were predicted to be antigenic by publically available 
computer algorithms. T-cell epitopes are indicated in blue, B-cell epitopes are indicated in green, and yellow areas 
indicate regions predicted to be antigenic to both. To the right of the sequences is a map of the antigenicity across the 
sequence where yellow peaks are indicative of high predicted antigenicity and green peaks indicate low predicated 
antigenicity. 
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Because the spliced construct at 1,684 bp was similar in nucleotide length to the 
pMA-RQ plasmid at 2,343 bp, the digested insert and plasmid did not separate well in 
agarose gel electrophoresis as shown in Figure 18a. Therefore, an additional digestion of 
pMA-RQ was required with SmlI (New England Biolabs). After pMA-RQ digestion by 
SmlI, plasmid fragments were well separated from the band corresponding to AAS4-6-
8sc as shown in the figure. Successful ligation of AAS4-6-8sc into pRSET-A and 
pPICZα-A and transformation into BL21 and X-33 cells is shown in Figure 18b and c.  
 
TQNPSSNVFIAAAFGMAYAGARGSSEAEVGLTFANEG
PRVAARGKTRGKIDGILPEGQPILFIVNAVYKFDPANTE
NKTEVSKHAAAVEIPYSGDHAAAVEIPYSGDHAAAVE
IPYSGDHAAAVEIPYSGDDSPTGLANFTGIVEVNEEGT
IAAPLPPIQFTVDRPFLYYETDDALLAKAQNPSSNVFT
GAGGSSEAESPNVFANEGSRVAARGKTRGKPEGQQF
DPSQTKDKPFLNQGTTEVSKPANFSAISESTQIYANFS
AISESTQIYANFSAISESTQIYANFSAISESTQIYVEVNE
EGTVATLHTPPPPIQFIVDRPFLYYQEEQKVANANPASS
EVNVFFSPYPASSEVNVFFSPYPASSEVNVFFSPYPASS
EVNVFFSPYPASSEVNVFFSPYSVSTALAMAYAGARG
ETQQELYSSAGLAPDHVPNAHAQHTQALKSPSSNTAV
VQEGYSAEVSTTNLADEKHHTDGPLSSDARFVLLTER
VGYARDDETNSDVVDLPYGYARDDETNSDVVDLPYG
YARDDETNSDVVDLPYGYARDDETNSDVVDLPY 
Figure 17. Spliced amino acid construct of AAS4, 6, and 8 
predicted epitopes. Putatively immunogenic amino acid regions were 
spliced together into one sequence. AAS4 is indicated in blue, AAS6 in 
green, and AAS8 in red. The first tandemly duplicated is underlined 
and repated four times. 
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Table 7: Putative T-cell epitopes and IEDB scores for AAS4, 6, and 8 
Serpin Epitope Score 
AAS4 IAAAFGMAY 2.3377 
 ILFIVNAVY 0.8272 
 HAAAVEIPY 0.8977 
 FTVDRPFLY 1.7274 
 TVDRPFLYY 4.0434 
AAS6 ETDDALLAK 1.3692 
 IAAAFGMAY 2.3377 
 ILFILNAVY 0.8541 
 AISESTQIY 2.0485 
 ISESTQIYI 0.8124 
 IVDRPFLYY 4.0600 
AAS8 EVNVFFSPY 1.6841 
 ASSEVNVFF 1.3000 
 VSTALAMAY 3.2479 
 NTAVVQEGY 2.2892 
 SSDARFVLL 1.0924 
 NSDVVDLPY 5.3122 
 
 
Expression of immunogenic AAS-4-6-8 spliced construct was unsuccessful 
The predicted molecular weight of rAAS4-6-8sc was 64.3 kDa. When the soluble 
and insoluble fractions of BL21-expressed protein were analyzed by western blot with 
chromogenic detection as shown in Figure 19, bands at this predicted molecular weight 
could not be detected. Pilot expressions were performed for six positive colonies, 
however, no bands at the expected molecular weight could be detected as shown in 
Figure 19a-d. Expression results were variable, with either no protein expression 
detected (Figure 19a), or bands appeared that were not of the expected molecular weight 
(Figure 19b-d).  One possibility is that the recombinant protein was truncated during 
expression, and this could explain the results seen in Figure 19b and c. As an alternative 
strategy, the ORF for AAS4-6-8sc was re-synthesized for expression in P. pastoris X-33  
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pPICZα-A  
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pMA-RQ 
AAS4-6-8 
AAS4-6-8 
pMA-RQ 
fragments 
C 
DH5α DH5α 
BL21  X-33  
Figure 18. Cloning of AAS4-6-8sc into pRSET-A and pPICZα-A for recombinant protein expression. The left picture 
in panel A shows pMA-RQ plasmid digestion with KpnI and BamHI with AAS4-6-8 insert release. As indicated by the 
orange arrow, the plasmid band at 2.3 kb is not well separated from the insert band, indicated by the blue arrow, which is 1.6 
kb. The right picture in Panel A shows pMA-RQ plasmids after further digestion with SmlI. The insert, indicated by the blue 
arrow, is well separated from the resulting plasmid fragments, indicated by the orange arrows. Panel B shows pRSET-A-
AAS4-6-8 successfully transformed into E. coli DH5α and BL21 cells. Panel C shows pPICZα-A-AAS4-6-8 successfully 
transformed into E. coli DH5α and X-33 cells.  
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Figure 19. Western blot analysis of AAS4-6-8sc expression in E. coli BL21. As the figure shows, pilot 
expressions of positively transformed BL21 colonies resulted in either no protein expression as shown in 
Panel A, expression of protein smaller than the expected size of 64.3 kDa as shown in Panels B and C, or 
expression of protein larger than the expected size as shown in Panel D.  
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from GeneArt. Although successful transformation of pPicZα-A-AAS4-6-8sc into P. 
pastoris was confirmed as shown in Figure 18c, western blot analysis of pilot 
expressions was negative. 
Protein expression in bacterial systems can fail for many reasons. It is possible 
that E. coli cells eject plasmids during culture. It is suggested that the use of carbenicillin 
instead of ampicillin could be a solution to this problem. Also, expressed protein can be 
toxic to the host cell, although the expression system used in this dissertation, BL21 
pLysS DE3 is among the tighter regulation systems to control for this problem (Thermo 
Fisher, short URL: https://goo.gl/PGICkH). Another possibility is that the protein coded 
for by spliced amino acid fragments was not stable and therefore could not be expressed 
in any system. The fact that expression in both BL21 and X-33 systems was 
unsuccessful supports this idea.  
Failure to express the recombinant AAS4-6-8 spliced construct prevented 
proceeding with the remaining immunization and tick challenge experiments in this 
chapter as outlined in my proposal. An alternative strategy would be to design an ORF 
that includes longer stretches of the native amino acid configuration, or perhaps to 
reduce or eliminate the tandem antigen repeats that were designed into the ORF. Another 
possibility would be to break the ORF into small fragments. These fragments could be 
amplified individually from the pre-existing ORF, and expressed one at a time. These 
individual fragments could then be used in immunization trials as a cocktail.  
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CHAPTER V 
 
CONCLUSIONS 
 
Serpins arose as interesting targets for anti-tick vaccine inclusion when it was 
hypothesized that they may play a role in tick evasion of host defense pathways. While 
some studies had begun to find serpins in ticks, the full picture of tick serpins remained 
speculative. Whereas only 17 serpins had been found in A. americanum by 2007 
(Mulenga et al.), analysis of sequences deposited in GenBank suggested a much larger 
number of serpins for I. scapularis, leaving the serpin count in ticks as under-explored.  
In this research, an extensive analysis of transcripts in fed and unfed A. 
americanum male and female ticks, as well as MG and SG tissues across feeding time 
points revealed serpins to be a very large family in this species. One notable observation 
is the presence of most serpin transcripts in several different tick tissues. This indicates 
that the same serpins function in multiple places in the tick and are not spatio-temporally 
restricted. This is in-line with accumulating evidence that tick serpins are often 
inhibitory against multiple proteases (Chmelar et al., 2011; Mulenga et al., 2013b; Ibelli 
et al., 2014; Rodriguez-Valle et al., 2015; Kim et al., 2015a). On the other side, this data 
indicates that between ticks and their vertebrate hosts there are many serine proteases-
mediated pathways to be controlled. While serpins in ticks are being investigated by 
many research groups, tick proteases remain understudied. Alternatively, it could be that 
many serpins are simply redundant rather than having different targets. This would be an 
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indication that the role serpins play are critical to the point where redundancy is required 
to ensure proper functionality of those pathways. Unfortunately, redundancy undermines 
efforts to silence these targets as a means for biological characterization and as a means 
to control tick parasitism. At the very least, it may be necessary to take an exhaustive 
survey of serpins within a tick species and subsequently target highly similar serpins as a 
cluster.  
Biochemical characterization of just two of the 122 serpins in A. americanum 
supports the hypothesis that ticks use at least some of the serpins they express to 
counter-defend against the vertebrate defense pathways. Specifically, data in this 
dissertation indicate a role for AAS4 and 8 in anti-neutrophil and/or anti-mast cell 
activity, suggesting that A. americanum ticks use these proteins as part of their arsenal of 
anti-inflammatory proteins. These proteins were also found to be immunogenic and 
therefore not only injected into the host, but also make good candidates for assessing 
their utility in anti-tick vaccines.  
It will also be interesting to investigate whether there are patterns in serpin amino 
acid sequences that predict protease inhibitor profiles. As was observed for AAS4, 
annotations by BLAST searches alone do not provide reliable predictions with regard to 
the complete serpin inhibitor profile. For example, AAS4 was 73% similar to serpin-2 in 
H. longicornis which has been characterized as a thrombin inhibitor however, AAS4 
inhibited chymase, papain, and cathepsin G. As more data become available on which 
proteases are inhibited by certain serpins, in silico analyses may become predictive. It 
will also be particularly useful to have the genome for A. americanum and other 
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metastriate tick species. This will allow an analysis of the serpin gene to serpin transcript 
analysis and could reveal if there are alternative splicing mechanisms for tick serpins as 
there are in other organisms (Jiang et al., 1997; Krüger et al., 2002). Furthermore, an 
available genome would facilitate transcriptome assemblies and an assessment of 
variability for tick serpins.  
Data in this and other research show (Radulović et al., in preparation) certain 
blood components may affect the way that serpins function in the host. AAS8 bound to 
heparin, and while the functional significance of this binding remains uninvestigated, 
heparin binding to serpins in other studies shows that the binding may affect the way the 
serpin functions, taking away or adding, or reducing or increasing the inhibition 
(Radulović et al., in preparation). Furthermore, there are a variety of heparins each of 
which could have a different effect on serpin function. Future studies should investigate 
the protease inhibitor profile of AAS8 while bound to heparin to assess how 
functionality for this protein changes after binding.  
In conclusion, this dissertation has contributed to building a more complete 
picture of the extent and variability of the serpin family in ixodid ticks, as well as 
established the nomenclature for serpins in A. americanum. This research has also 
contributed towards further elucidating serpin function in tick feeding physiology by 
characterizing AAS4 and 8 as anti-inflammatory tick saliva proteins. Some of the most 
important remaining questions to be resolved include the significance of AAS8 binding 
to cofactor heparin, whether or not these proteins play dual functions in inhibiting 
endogenous and exogenous serpins, whether similar serpins derive from the same gene, 
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and whether or not their inclusion in vaccines can result in protection from tick feeding 
and/or pathogen transmission. 
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